CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS)
MASH
CHOLESTASIS
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Embassy of Education CLDF Committees
Embassy of Education
Publications Webcasts Algorithm Abstract Library Committee Members
 
HCC | Abstract Library
Abstract Library
 
Back
The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.
1.Genome-wide enhancer-gene regulatory maps of liver reveal novel regulatory mechanisms underlying NAFLD pathogenesis.
  BMC Genomics.2025 May 15;26(1):493.doi:10.1186/s12864-025-11668-w
  Li, Ruofan (R);Su, Kaiyan (K);Wu, Tianzhun (T);Xu, Li (L);Song, Wenyu (W);Sun, Dandan (D);Zeng, Tao (T);Chen, Jinzhang (J);Xin, Haibei (H);Li, Yuanfeng (Y);Zang, Mengya (M);Hu, Minggen (M);
 
2.Genome-Wide Methylation Sequencing to Identify DNA Methylation Markers for Early-stage Hepatocellular Carcinoma in Liver and Blood.
  J Exp Clin Cancer Res.2025 May 15;44(1):144.doi:10.1186/s13046-025-03412-9
  Fu, Siyu (S);Boers, Ruben G (RG);Boers, Joachim B (JB);van der Meeren, Pam E (PE);Helmijr, Jean (J);de Weerd, Vanja (V);Doukas, Michail (M);Jansen, Maurice (M);Hansen, Bettina E (BE);de Wilde, Roeland F (RF);Sprengers, Dave (D);Gribnau, Joost (J);Wilting, Saskia M (SM);Debes, José D (JD);Boonstra, Andre (A);
 
3.Carry-over effect of immunotherapy in patients with advanced hepatocellular carcinoma.
  Cancer Immunol Immunother.2025 May 16;74(7):208.doi:10.1007/s00262-025-04052-w
  Chuang, Chien-Huai (CH);Chen, Ching-Tso (CT);Hsu, Chih-Hung (CH);Shao, Yu-Yun (YY);
 
4.Identification of M0 macrophage associated lipid metabolism genes for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma.
  Discov Oncol.2025 May 16;16(1):781.doi:10.1007/s12672-025-02620-1
  Zhou, Huanjie (H);Lao, Ming (M);Liang, Zhengui (Z);Zhao, Huiliu (H);Wang, Ying (Y);Huang, Qiongqing (Q);Ou, Chao (C);
 
5.Lysionotin promoted apoptosis of hepatocellular carcinoma cells via inducing autophagy.
  Discov Oncol.2025 May 16;16(1):788.doi:10.1007/s12672-025-02503-5
  Wang, Xiaoxue (X);Zhong, Weiwei (W);Wang, Qin (Q);Song, Peng (P);Lin, Xia (X);Li, Bohan (B);Yin, Yancun (Y);Yang, Chunyan (C);Li, Minjing (M);
 
6.Autophagy-related gene SQSTM1 predicts the prognosis of hepatocellular carcinoma.
  Comput Biol Med.2025 May 15;192(Pt B):110358.doi:10.1016/j.compbiomed.2025.110358
  Zheng, Zhiming (Z);Xu, Haijiong (H);Luo, Lianxiang (L);
 
7.RALOX-HAIC (raltitrexed?+?oxaliplatin) combined with lenvatinib improves survival and safety in elderly patients with unresectable hepatocellular carcinoma.
  BMC Cancer.2025 May 16;25(1):882.doi:10.1186/s12885-025-14274-x
  Lu, Haohao (H);Gao, Ya (Y);Xia, Xiangwen (X);Fu, Qing (Q);Xiang, Dongqiao (D);
 
8.Predictive value of intra-hepatectomy ICGR15 of the remnant liver for post-hepatectomy liver failure in hemi-hepatectomy: a prospective study.
  BMC Cancer.2025 May 16;25(1):881.doi:10.1186/s12885-025-14296-5
  Liang, Tianyi (T);He, Yongfei (Y);Mo, Shutian (S);Liao, Yuan (Y);Huang, Ketuan (K);Gao, Qiang (Q);Shen, Xiaoqiang (X);Yang, Chengkun (C);Liao, Xiwen (X);Qin, Wei (W);Zhu, Guangzhi (G);Su, Hao (H);Ye, Xinping (X);Han, Chuangye (C);Peng, Tao (T);
 
9.Overexpression of MCL-1 in canine hepatocellular carcinoma and its efficacy as a prognostic marker.
  BMC Vet Res.2025 May 16;21(1):349.doi:10.1186/s12917-025-04798-6
  Baek, Jehun (J);Cho, Jaeho (J);Shin, Hun-Kyeong (HK);Kim, Wan Hee (WH);
 
10.A novel pH-sensitive nanoparticles encapsulating anti-PD-1 antibody and MDK-siRNA overcome immune checkpoint blockade resistance in HCC via reshaping immunosuppressive TME.
  J Exp Clin Cancer Res.2025 May 16;44(1):148.doi:10.1186/s13046-025-03396-6
  Xu, Hai (H);Li, Shuo (S);Liu, Yifan (Y);Sung, Yoon-Young (YY);Zhou, Yong (Y);Wu, Huikun (H);
 
11.Serum interferon-gamma-induced protein 10 levels can help predict sarcopenia development in patients with primary hepatocellular carcinoma: A retrospective cohort study.
  PLoS One.2025 May 15;20(5):e0309852.doi:10.1371/journal.pone.0309852
  Takada, Hitomi (H);Osawa, Leona (L);Komiyama, Yasuyuki (Y);Muraoka, Masaru (M);Suzuki, Yuichiro (Y);Sato, Mitsuaki (M);Kobayashi, Shoji (S);Yoshida, Takashi (T);Takano, Shinichi (S);Maekawa, Shinya (S);Enomoto, Nobuyuki (N);
 
12.Acute Liver Failure due to Wilson's Disease and Rescue Therapy with Plasma Exchange: A Case Report and Literature Review.
  Case Rep Gastroenterol.2025 May 13;19(1):340-351.doi:10.1159/000544927
  Hajijama, Sameera (S);Marashi, Mahmoud (M);Ho, Samuel B (SB);
 
13.Platelet-albumin-bilirubin versus albumin-bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resection.
  BMC Cancer.2025 May 12;25(1):855.doi:10.1186/s12885-025-14240-7
  Yang, Haojie (H);Shen, Shuang (S);Yang, Yuting (Y);Zhou, Houping (H);Xiang, Bangde (B);
 
14.A network meta-analysis of different interventional treatment strategies for unresectable hepatocellular carcinoma.
  BMC Gastroenterol.2025 May 12;25(1):360.doi:10.1186/s12876-025-03980-2
  Le, Xing-Yan (XY);Feng, Jun-Bang (JB);Yu, Xiao-Li (XL);Li, Sui-Li (SL);Zhang, Xiaocai (X);Li, Jiaqing (J);Li, Chuan-Ming (CM);
 
15.Development of a chitosanase 3-like protein 1 assay kit and study of its application in patients with hepatocellular carcinoma.
  BMC Biotechnol.2025 May 12;25(1):35.doi:10.1186/s12896-025-00970-w
  Liu, Min (M);Qiu, Yanru (Y);Xie, Erfu (E);Qian, Pu (P);Yang, Shuxian (S);Zhao, Simin (S);Yan, Wenjun (W);Huang, Xuan (X);Han, Shuang (S);
 
16.Machine learning predicts prognosis in patients with gastroenteropancreatic neuroendocrine tumors with liver metastases.
  Discov Oncol.2025 May 12;16(1):743.doi:10.1007/s12672-025-02579-z
  Gao, Fuli (F);Chen, Jian (J);Xu, Xiaodan (X);
 
17.Heparinase I treatment to overcome RNA quantification interference in heparinized liver donor samples: One size fits all?
  PLoS One.2025 May 12;20(5):e0322899.doi:10.1371/journal.pone.0322899
  Dalmau, Mar (M);Charco, Ramón (R);Bilbao, Itxarone (I);Dopazo, Cristina (C);Caralt, Mireia (M);Molino, José Andrés (JA);Gómez-Gavara, Concepción (C);
 
18.Prognostic Effect of CEA Cut-Off in Patients with Resectable Colorectal Liver Metastases: A Meta-Analysis and Meta-Regression.
  J Gastrointest Cancer.2025 May 13;56(1):117.doi:10.1007/s12029-025-01244-6
  Venturino, Antonella (A);Colloca, Giuseppe A (GA);
 
19.Vancomycin Therapy for Induction and Maintenance of Remission in a Patient with Refractory Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report and Literature Review.
  Case Rep Gastroenterol.2025 May 06;19(1):320-327.doi:10.1159/000544161
  Lang, Naama (N);Davidov, Yana (Y);Hoffman, Tomer (T);Harnik, Sivan (S);Eliakim, Abraham Rami (AR);Ben-Horin, Shomron (S);Ungar, Bella (B);
 
20.The association between the intake of polyunsaturated fatty acids and chronic constipation and diarrhea: NHANES 2005-2010.
  Lipids Health Dis.2025 May 06;24(1):164.doi:10.1186/s12944-025-02570-1
  Lin, Ping (P);Wang, Wei (W);Zhou, Yun (Y);Yang, Yong (Y);Liu, Ping (P);
 
21.Usual walking Pace and risk of 28 cancers- results from the UK biobank.
  BMC Cancer.2025 May 14;25(1):869.doi:10.1186/s12885-025-14258-x
  Stein, Michael J (MJ);Baurecht, Hansjörg (H);Bohmann, Patricia (P);Ferrari, Pietro (P);Fervers, Béatrice (B);Fontvieille, Emma (E);Freisling, Heinz (H);Friedenreich, Christine M (CM);Gunter, Marc J (MJ);Peruchet-Noray, Laia (L);Sedlmeier, Anja M (AM);Weber, Andrea (A);Leitzmann, Michael F (MF);Konzok, Julian (J);
 
22. as a prognostic and diagnostic marker is a possible key contributor in hepatocellular carcinoma.
  Transl Cancer Res.2025 Apr 15;14(4):2303-2318.doi:10.21037/tcr-24-1845
  Ding, Jun (J);Deng, Ya-Ting (YT);Deng, Yi (Y);Chen, Ke-Ying (KY);Guo, Peng (P);Han, Fei (F);
 
23.Multi-omics analyses develop and validate the optimal prognostic model on overall survival prediction for resectable hepatocellular carcinoma.
  J Gastrointest Oncol.2025 Apr 27;16(2):628-649.doi:10.21037/jgo-24-710
  Han, Ying (Y);Zeng, Ajuan (A);Liang, Xueying (X);Jiang, Yingying (Y);Wang, Fenglin (F);Song, Lele (L);
 
24.A retrospective database analysis to understand treatment patterns and outcomes of intermediate and advanced hepatocellular carcinoma in Alberta, Canada (A-CAPTAIN study).
  J Gastrointest Oncol.2025 Apr 27;16(2):650-659.doi:10.21037/jgo-24-692
  Amaro, Carla P (CP);Lim, Chloe A (CA);Ding, Philip Q (PQ);Cheung, Winson Y (WY);Syed, Iqra (I);Kim, YongJin (Y);Shephard, Cal (C);Wang, Sharon (S);Clouthier, Derek L (DL);Tam, Vincent C (VC);
 
25.Inhibition of hepatocellular carcinoma progression by artesunate via modulation of the TLR4/MyD88/NF-?B signaling pathway.
  J Gastrointest Oncol.2025 Apr 27;16(2):599-614.doi:10.21037/jgo-2025-95
  Wu, Yongchao (Y);Wu, Jianhua (J);Li, Zhigang (Z);Wu, Zhonglin (Z);Li, Shunzong (S);Yang, Guang (G);Rong, Xiaocui (X);Wang, Qi (Q);Li, Yazhou (Y);Xia, Qingqing (Q);Shi, Gaofeng (G);
 
26.Safranal-loaded gold nanoparticles alleviate hepatocellular carcinoma via targeting the Wnt/?-catenin pathway.
  Discov Oncol.2025 May 19;16(1):821.doi:10.1007/s12672-025-02447-w
  Samra, Yara A (YA);Abd El Salam, Al Shaima G (ASG);Abdelghany, Amr M (AM);El-Shishtawy, Mamdouh M (MM);
 
27.From genes to therapy: a lipid Metabolism-Related genetic risk model predicts HCC outcomes and enhances immunotherapy.
  BMC Cancer.2025 May 19;25(1):895.doi:10.1186/s12885-025-14306-6
  Xu, Lei (L);Xiao, Ting (T);Chao, Tengfei (T);Xiong, Huihua (H);Yao, Wei (W);
 
28.Biomarker, efficacy and safety analysis of transcatheter arterial chemoembolization combined with atezolizumab and bevacizumab for unresectable hepatocellular carcinoma.
  Cancer Immunol Immunother.2025 May 19;74(7):209.doi:10.1007/s00262-025-04058-4
  Zhang, Shaobo (S);Zhu, Zebin (Z);Liu, Lianxin (L);Nashan, Björn (B);Zhang, Shugeng (S);
 
29.Prediction of prognosis of immune checkpoint inhibitors combined with anti-angiogenic agents for unresectable hepatocellular carcinoma by machine learning-based radiomics.
  BMC Cancer.2025 May 19;25(1):888.doi:10.1186/s12885-025-14247-0
  Xu, Xuni (X);Jiang, Xue (X);Jiang, Haoran (H);Yuan, Xiaoye (X);Zhao, Mengjing (M);Wang, Yuqi (Y);Chen, Gang (G);Li, Gang (G);Duan, Yuxia (Y);
 
30.Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial.
  BMC Cancer.2025 May 07;25(1):838.doi:10.1186/s12885-025-14250-5
  Yalikun, Kugeluke (K);Li, Zhongchao (Z);Zhang, Jianxin (J);Chang, Zhibin (Z);Li, Mingming (M);Sun, Zhicheng (Z);Liu, Zhaogang (Z);Yang, Yue (Y);Xu, Lei (L);Li, Lei (L);Zhang, Chengsheng (C);Sun, Pengfei (P);Zhong, Jingtao (J);Cui, Kai (K);Shi, Xuetao (X);Zhang, Bo (B);Zhao, Lei (L);
 
31.FTO downregulation-mediated m6A modification resulting in enhanced hepatocellular carcinoma invasion.
  Cell Biosci.2025 May 02;15(1):58.doi:10.1186/s13578-025-01395-w
  Zhou, Cheng (C);Zhang, Yong (Y);Shi, Shi-Ming (SM);Yin, Dan (D);Li, Xue-Dong (XD);Shi, Ying-Hong (YH);Zhou, Jian (J);Wang, Zheng (Z);Chen, Qing (Q);
 
32.Decoding per- and polyfluoroalkyl substances (PFAS) in hepatocellular carcinoma: a multi-omics and computational toxicology approach.
  J Transl Med.2025 May 02;23(1):504.doi:10.1186/s12967-025-06517-z
  Hong, Yanggang (Y);Wang, Deqi (D);Liu, Zeyu (Z);Chen, Yuxin (Y);Wang, Yi (Y);Li, Jiajun (J);
 
33.Enhancing F-FDG PET image quality and lesion diagnostic performance across different body mass index using the deep progressive learning reconstruction algorithm.
  Cancer Imaging.2025 May 01;25(1):58.doi:10.1186/s40644-025-00877-x
  Chen, Zhihao (Z);Yang, Hongxing (H);Qi, Ming (M);Chen, Wen (W);Liu, Fei (F);Song, Shaoli (S);Zhang, Jianping (J);
 
34.Oncologic effect of preoperative endoscopic sphincterotomy in patients undergoing pancreaticoduodenectomy for ampulla of vater cancer.
  Langenbecks Arch Surg.2025 May 16;410(1):161.doi:10.1007/s00423-025-03730-8
  Jeon, Su Min (SM);Choi, Yoo Jin (YJ);Jo, Hye-Sung (HS);Choi, Sae Byeol (SB);Kim, Wan-Bae (WB);Han, Hyung-Joon (HJ);Song, Tae Jin (TJ);Kim, Dong-Sik (DS);Yu, Young-Dong (YD);
 
35.Number of Intravenous Insertions Per Week Does Not Influence Infusion Nurses' Ratings of Risk Factors for Difficult Intravenous Access (DIVA).
  J Infus Nurs.2025 Apr 29;48(3):206-213.doi:10.1097/NAN.0000000000000590
  Alfaro, Emely (E);Ejercito, Ruby (R);Canote, Marissa (M);Cosgrove, Teresa (T);Hawker, Jung-Ja (JJ);Quinn, Marisa (M);Miaskowski, Christine (C);
 
36.Clinical and safety outcomes in unresectable, very early and early-stage hepatocellular carcinoma following Irreversible Electroporation (IRE) and Transarterial Chemoembolization (TACE): A systematic literature review and meta-analysis.
  PLoS One.2025 Apr 29;20(4):e0322113.doi:10.1371/journal.pone.0322113
  Cribbs, Kristen A (KA);Baisley, Wesley T (WT);Lahue, Betsy J (BJ);Peddu, Praveen (P);
 
37.Grading risk of microvascular invasion impacts survival in hepatocellular carcinoma patients undergoing adjuvant transarterial chemoembolization: A multicenter study.
  Eur J Surg Oncol.2025 Apr 24;51(8):110102.doi:10.1016/j.ejso.2025.110102
  Lu, Jin-Pian (JP);Feng, Jin-Kai (JK);Zhao, Yang (Y);Chen, Bin (B);Li, Peng-Ping (PP);He, Chao (C);Gong, Lin (L);Bao, Ling-Ling (LL);
 
38.Survival assessment and pre-diagnostic risk factors for lung cancer incidence: Insights from the Golestan Cohort Study.
  PLoS One.2025 Apr 29;20(4):e0320931.doi:10.1371/journal.pone.0320931
  Mousavi, Seyedeh Fatemeh (SF);Masoudi, Sahar (S);Rezaei, Negar (N);Pourghazi, Farzad (F);Sharafkhah, Maryam (M);Eslami, Maysa (M);Pourshams, Akram (A);Poustchi, Hossein (H);Roshandel, Gholamreza (G);Aliannejad, Rasoul (R);Sepanlou, Sadaf G (SG);Malekzadeh, Reza (R);
 
39.Development of a nomogram for overall survival prediction in primary upper lobe lung cancer patients: A SEER population-based analysis.
  PLoS One.2025 Apr 29;20(4):e0321955.doi:10.1371/journal.pone.0321955
  Yu, Wenze (W);Long, Lu (L);Hou, Qizhuo (Q);Yi, Bin (B);
 
40.Predictors for psychosocial consequences of screening for liver diseases: A data-driven approach.
  PLoS One.2025 Apr 29;20(4):e0319488.doi:10.1371/journal.pone.0319488
  Fichtner, Urs Alexander (UA);Maun, Andy (A);Farin-Glattacker, Erik (E);
 
41.Mutational status of RAS, SMAD4 and APC predicts survival after resection of colorectal liver metastases in Chinese patients: prognostic stratification based on genetic sequencing data of multiple somatic genes.
  World J Surg Oncol.2025 Apr 29;23(1):172.doi:10.1186/s12957-025-03755-9
  Chen, Wen-Jia (WJ);Wang, Hong-Wei (HW);Wang, Li-Jun (LJ);Xu, Da (D);Liu, Ming (M);Xing, Bao-Cai (BC);
 
42.Combined unrelated donor allogeneic hematopoietic stem cell transplantation and unrelated cord blood transfusion for patients with hematological malignancies.
  Hematology.2025 Apr 29;30(1):2496543.doi:10.1080/16078454.2025.2496543
  Wang, Nana (N);Jiang, Yizhi (Y);Wei, Zhongling (Z);Yang, Yuqiong (Y);Huang, Jun (J);Huang, Chen (C);Qi, Jing (J);Yan, Jiawei (J);Wang, Ran (R);Zhang, Lanxin (L);Huang, Dongping (D);
 
43.Skeletal muscle index/systemic immune-inflammation index (SMI/SII) ratio predicts prognosis in patients with hepatocellular carcinoma.
  World J Surg Oncol.2025 May 04;23(1):178.doi:10.1186/s12957-025-03826-x
  Li, Shu-Xian (SX);Huang, Wei (W);Li, Jun-Xiang (JX);An, Tian-Zhi (TZ);Li, Hui-Zhou (HZ);Hu, Chao (C);Xiao, Yu-Dong (YD);Wang, Tian-Cheng (TC);
 
44.Anxiety is a risk prognosis factor for hepatocellular carcinoma with portal vein tumor thrombus who underwent hepatic arterial infusion chemotherapy: a propensity score-matching cohort study.
  World J Surg Oncol.2025 May 14;23(1):189.doi:10.1186/s12957-025-03845-8
  Tan, Hao-Yang (HY);Liu, Shuang-Quan (SQ);Liu, Yan-Han (YH);Lu, Ling (L);Zheng, Jiu-Ling (JL);Feng, Hua-Guo (HG);
 
45.Comparison of initial treatments for resectable hepatocellular carcinoma within Milan criteria: an observational study based on a nationwide survey.
  Ann Surg Treat Res.2025 Apr 28;108(5):279-294.doi:10.4174/astr.2025.108.5.279
  Kim, Sang Jin (SJ);Jeong, Woo Kyoung (WK);Han, Hyung-Joon (HJ);Choi, Gyu-Seong (GS);Kim, Kyun-Hwan (KH);Kim, Jongman (J);
 
46.Integrative analysis of the expression profile and prognostic values of SENP gene family in hepatocellular carcinoma.
  Discov Oncol.2025 May 13;16(1):752.doi:10.1007/s12672-025-02598-w
  Zhang, Xu (X);Zhao, Chenglei (C);Liu, Tianyi (T);
 
47.Noninvasive prognostication of hepatocellular carcinoma based on cell-free DNA methylation.
  PLoS One.2025 Apr 25;20(4):e0321736.doi:10.1371/journal.pone.0321736
  Hu, Ran (R);Tran, Benjamin (B);Li, Shuo (S);Stackpole, Mary L (ML);Zeng, Weihua (W);Zhou, Yonggang (Y);Melehy, Andrew (A);Sadeghi, Saeed (S);Finn, Richard S (RS);Zhou, Xianghong Jasmine (XJ);Li, Wenyuan (W);Agopian, Vatche G (VG);
 
48.Integration of single-cell sequencing and mendelian randomization reveals novel causal pathways between monocytes and hepatocellular carcinoma.
  Discov Oncol.2025 Apr 24;16(1):604.doi:10.1007/s12672-025-02357-x
  Yu, Jiang (J);Yu, Jing (J);Kang, Zhou (Z);Peng, Yong (Y);
 
49.Imaging-based assessment of muscles and malnutrition predict prognosis in patients with primary hepatocellular carcinoma.
  PLoS One.2025 Apr 24;20(4):e0307458.doi:10.1371/journal.pone.0307458
  Takada, Hitomi (H);Osawa, Leona (L);Komiyama, Yasuyuki (Y);Muraoka, Masaru (M);Suzuki, Yuichiro (Y);Sato, Mitsuaki (M);Kobayashi, Shoji (S);Yoshida, Takashi (T);Takano, Shinichi (S);Maekawa, Shinya (S);Enomoto, Nobuyuki (N);
 
50.Resection and partial liver transplantation from deceased donors with delayed total hepatectomy (RAPID procedure) for hepatocellular carcinoma: a national, multicenter, non-randomized, prospective trial.
  BMC Cancer.2025 May 09;25(1):848.doi:10.1186/s12885-025-14127-7
  Peloso, Andrea (A);Pietrasz, Daniel (D);Daillier, Etienne (E);Cylly, Laurent (L);Scatton, Olivier (O);Goumard, Claire (C);Mabrut, Jean-Yves (JY);Mohkam, Kayvan (K);Lesurtel, Mickael (M);Dokmak, Safi (S);Jeddou, Heithem (H);Boudjema, Karim (K);Allard, Marc-Antoine (MA);Adam, René (R);Sa Cunha, Antonio (A);Azoulay, Daniel (D);Cherqui, Daniel (D);Vibert, Eric (E);Golse, Nicolas (N);
 
51.Hepatic artery infusion of FOLFOX chemotherapy plus camrelizumab combined with sorafenib for advanced hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (Double-IA-001): a phase II trial.
  BMC Med.2025 May 09;23(1):275.doi:10.1186/s12916-025-04110-1
  Shen, Lujun (L);Cao, Fei (F);Liu, Ying (Y);Nuerhashi, Gulijiayina (G);Lin, Letao (L);Tan, Hontong (H);Wen, Chunyong (C);Wang, Yujia (Y);Chen, Shuanggang (S);Zou, Hongliang (H);Xie, Lin (L);Fan, Weijun (W);
 
52.Radiotherapy, tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion chemotherapy of RALOX versus FOLFOX for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score-matching cohort study.
  Discov Oncol.2025 May 10;16(1):717.doi:10.1007/s12672-025-02553-9
  Tan, Hao-Yang (HY);Liu, Shuang-Quan (SQ);Liu, Yan-Han (YH);Dai, Guo-Hua (GH);Zheng, Jiu-Ling (JL);Feng, Hua-Guo (HG);
 
53.Unsupervised machine learning-based stratification and immune deconvolution of liver hepatocellular carcinoma.
  BMC Cancer.2025 May 10;25(1):853.doi:10.1186/s12885-025-14242-5
  Reierson, Mae Montserrat (MM);Acharjee, Animesh (A);
 
54.Prior Immune Checkpoint Inhibitor Treatment Is a Risk Factor for Treatment-Related Adverse Events in Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab.
  JGH Open.2025 Apr 23;9(4):e70163.doi:10.1002/jgh3.70163
  Watanabe, Naohiro (N);Kobayashi, Takashi (T);Iwaki, Michihiro (M);Nogami, Asako (A);Wada, Naohiro (N);Shimizu, Ayako (A);Komori, Tomoya (T);Koike, Hirofumi (H);Sahashi, Yukiko (Y);Nakajima, Atsushi (A);Yoneda, Masato (M);
 
55.Disease Burden of 30 Cancer Groups in Taiwan from 2000 to 2021.
  J Epidemiol Glob Health.2025 Apr 22;15(1):62.doi:10.1007/s44197-025-00406-w
  Liu, Po-Chen (PC);Huang, Tzu-Hsuan (TH);Wu, Yun-Chun (YC);Wang, Yueh (Y);Chiang, Chun-Ju (CJ);Lee, Wen-Chung (WC);Lin, Hsien-Ho (HH);Lo, Wei-Cheng (WC);
 
56.Impact of neutrophil-to-lymphocyte ratio on survival outcomes among cirrhotic and non-cirrhotic patients with advanced hepatocellular carcinoma under atezolizumab-bevacizumab combination therapy.
  Ann Gastroenterol.2025 Apr 22;38(3):319-327.doi:10.20524/aog.2025.0963
  Pantzios, Spyridon (S);Sidiropoulos, Orestis (O);Syriha, Antonia (A);Stathopoulou, Ioanna (I);Rellou, Sofia (S);Nychas, Emmanouil (E);Barla, Georgia (G);Ptohis, Nikolaos (N);Elefsiniotis, Ioannis (I);
 
57.Plasma protein levels and hepatocellular carcinoma: a Mendelian randomization study with drug screening implications.
  Discov Oncol.2025 Apr 19;16(1):567.doi:10.1007/s12672-025-02307-7
  Xie, Longhui (L);Song, Dekun (D);Lan, Jianwei (J);Liu, Pengpeng (P);Qin, Shuang (S);Ning, Yinkuan (Y);Liu, Quanyan (Q);
 
58.Efficacy and safety of image-guided hypofractionated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective, multicenter study.
  BMC Cancer.2025 Apr 21;25(1):736.doi:10.1186/s12885-025-13739-3
  Lee, Sang Min (SM);Choi, Jin Hwa (JH);Yoon, Jung-Hwan (JH);Kim, Yoon Jun (YJ);Yu, Su Jong (SJ);Lee, Jeong-Hoon (JH);Kang, Hyun-Cheol (HC);Chie, Eui Kyu (EK);Kim, Kyung Su (KS);
 
59.Splicing factor PTBP1 promotes hepatocarcinogenesis via oncogenic splice-switching of MAPT.
  Oncol Res.2025 Apr 18;33(5):1121-1133.doi:10.32604/or.2025.060958
  Zheng, Wenying (W);Shang, Yanyan (Y);DU, Kai (K);Luo, Ailing (A);Pei, Lijun (L);Li, Meiqi (M);Zhang, Guoping (G);Deng, Min (M);
 
60.Preoperative prediction of microvascular invasion and relapse-free survival in hepatocellular Carcinoma ?3 cm using CT radiomics: Development and external validation.
  BMC Med Imaging.2025 May 01;25(1):141.doi:10.1186/s12880-025-01677-2
  Zhong, Hua (H);Zhang, Yan (Y);Zhu, Guanbin (G);Zheng, Xiaoli (X);Wang, Jinan (J);Kang, Jianghe (J);Lin, Ziying (Z);Yue, Xin (X);
 
61.Increased expression of DNAJC7 promotes the progression of hepatocellular carcinoma by influencing the cell cycle and immune microenvironment.
  J Cancer Res Clin Oncol.2025 May 02;151(5):154.doi:10.1007/s00432-025-06202-0
  Chen, Jiaxing (J);Yang, Zhizhao (Z);Cui, Yongqiang (Y);Zhao, Zhilei (Z);Deng, Dongfeng (D);Fu, Zhihao (Z);Zhang, Xiao (X);
 
62.RGS14 promotes the progression of hepatocellular carcinoma by activating the cAMP/PKA/CREB signaling pathway.
  J Cancer Res Clin Oncol.2025 May 02;151(5):153.doi:10.1007/s00432-025-06212-y
  Liang, Xiangnan (X);Xu, Bin (B);Wang, Qiuxiang (Q);Gong, Kai (K);Han, Chun (C);Sun, Binwen (B);Ma, Kexin (K);Wang, Liming (L);
 
63.LncRNA PVT1 activated by TGF-?1/Smad3 facilitates proliferation and metastasis of hepatocellular carcinoma via upregulating Smad6 and NRG1.
  J Transl Med.2025 May 01;23(1):500.doi:10.1186/s12967-025-06229-4
  Wu, Shuaihui (S);Cheng, Qian (Q);Shi, Yang (Y);Wang, Kunlei (K);Chen, Zhinan (Z);Li, Xinyin (X);Jiang, Ping (P);Cheng, Zhixiang (Z);Yang, Zhiyong (Z);Liao, Bo (B);
 
64.Increased morbidity associated with secondary abdominal closure in pediatric liver transplantation.
  World J Pediatr Surg.2025 Apr 15;8(2):e000975.doi:10.1136/wjps-2024-000975
  Costa, Carolina Magalhães (CM);Fonseca, Eduardo A (EA);Pugliese, Renata (R);Benavides, Marcel R (MR);Vincenzi, Rodrigo (R);Rangel, Nathália P T (NPT);Oliveira, Caio M (CM);Roda, Karina (K);Fernandes, Debora P (DP);Seda Neto, João (J);
 
65.A nomogram for prognostic prediction and for therapeutic decision making of elderly HCC patients.
  BMC Gastroenterol.2025 Apr 15;25(1):257.doi:10.1186/s12876-025-03823-0
  Liu, Shuyu (S);Zhou, Mengyue (M);Chen, Peng (P);Deng, Xueting (X);Gu, Jiayi (J);Miao, Lin (L);
 
66.SF3B4 regulates proliferation and apoptosis in hepatocellular carcinoma via alternative splicing and interaction with TRIM28 and SETD5.
  J Transl Med.2025 Apr 15;23(1):441.doi:10.1186/s12967-025-06420-7
  Huang, HanFei (H);Fang, Yuan (Y);Li, ZhiTao (Z);Qu, SiMing (S);Yuan, Bo (B);Gan, Kai (K);Yue, ChengLong (C);Li, HaiJing (H);Wen, YuBo (Y);Zeng, Zhong (Z);
 
67.Palliative and supportive care in patients with hepatocellular carcinoma: a qualitative study on attitudes and perceptions of health professionals.
  Support Care Cancer.2025 Apr 16;33(5):384.doi:10.1007/s00520-025-09403-y
  Gofton, Cameron (C);Bartolomeo, Anna Di (AD);Wijekulasuriya, Shalini (S);Cai, Shenghan (S);Boutros, Rose (R);Stafford-Bell, Fiona (F);Caldwell, Kim (K);McCaughan, Geoffrey (G);Zekry, Amany (A);Strasser, Simone I (SI);Levy, Miriam (M);Sheehan, Caitlin (C);Goodall, Stephen (S);Davis, Jan Maree (JM);Sheahan, Linda (L);Liu, Ken (K);Greenaway, Sally (S);Davison, Scott (S);Huynh, Thang Du (TD);Quadri, Zujaj (Z);Zurynski, Yvonne A (YA);Agar, Meera (M);George, Jacob (J);
 
68.Transversalis fascia collagen content and the risk of surgical complications: results of a prospective study.
  Langenbecks Arch Surg.2025 Apr 16;410(1):130.doi:10.1007/s00423-025-03706-8
  Morawski, Marcin (M);Krasnod?bski, Maciej (M);Rocho?, Jakub (J);Kubiszewski, Hubert (H);Staszewski, Miko?aj (M);Kuncewicz, Miko?aj (M);Krawczyk, Piotr (P);Rykowski, Pawe? (P);Bo?tu?, Adam (A);Lewandowski, Zbigniew (Z);Figiel, Wojciech (W);Krawczyk, Marek (M);Gr?t, Micha? (M);
 
69.Different cutoff values of the skeletal muscle mass and myosteatosis result in different clinical impact on overall survival in oncology. A subanalysis of a clinical trial.
  J Cancer Res Clin Oncol.2025 Apr 16;151(4):141.doi:10.1007/s00432-025-06190-1
  Surov, Alexey (A);Thormann, Maximilian (M);Wienke, Andreas (A);Ricke, Jens (J);Seidensticker, Max (M);
 
70.Colorectal cancer progression to metastasis is associated with dynamic genome-wide biphasic 5-hydroxymethylcytosine accumulation.
  BMC Biol.2025 Apr 16;23(1):100.doi:10.1186/s12915-025-02205-y
  Murcott, Ben (B);Honig, Floris (F);Halliwell, Dominic Oliver (DO);Tian, Yuan (Y);Robson, James Lawrence (JL);Manasterski, Piotr (P);Pinnell, Jennifer (J);Dix-Peek, Thérèse (T);Uribe-Lewis, Santiago (S);Ibrahim, Ashraf E K (AEK);Sero, Julia (J);Gurevich, David (D);Nikolaou, Nikolas (N);Murrell, Adele (A);
 
71.Fecal profiling reveals a common microbial signature for pancreatic cancer in Finnish and Iranian cohorts.
  Gut Pathog.2025 Apr 16;17(1):24.doi:10.1186/s13099-025-00698-0
  Sammallahti, Heidelinde (H);Rezasoltani, Sama (S);Pekkala, Satu (S);Kokkola, Arto (A);Asadzadeh Agdaei, Hamid (H);Azizmohhammad Looha, Mehdi (M);Ghanbari, Reza (R);Zamani, Farhad (F);Sadeghi, Amir (A);Sarhadi, Virinder Kaur (VK);Tiirola, Marja (M);Puolakkainen, Pauli (P);Knuutila, Sakari (S);
 
72.Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study.
  Cancer Chemother Pharmacol.2025 Apr 17;95(1):55.doi:10.1007/s00280-025-04776-7
  Nihei, Satoru (S);Saito, Kazuki (K);Ikeda, Tatsuki (T);Oikawa, Takayoshi (T);Asahi, Koichi (K);Asaka, Junichi (J);Kudo, Kenzo (K);
 
73.A deep learning model based on self-supervised learning for identifying subtypes of proliferative hepatocellular carcinoma from dynamic contrast-enhanced MRI.
  Insights Imaging.2025 Apr 17;16(1):89.doi:10.1186/s13244-025-01968-w
  Qu, Hui (H);Zhang, Shuairan (S);Li, Xuedan (X);Miao, Yuan (Y);Han, Yuxi (Y);Ju, Ronghui (R);Cui, Xiaoyu (X);Li, Yiling (Y);
 
74.miR-130a-5p/TFPI2 axis promotes invasion of hepatocellular carcinoma by altering epithelial-to-mesenchymal transition.
  Discov Oncol.2025 Apr 17;16(1):546.doi:10.1007/s12672-025-02296-7
  Gu, Xiaoyuan (X);Lu, Hongmin (H);Wang, Wei (W);Zhao, Zijun (Z);Zhang, Weiqiang (W);Lu, Xinyuan (X);
 
75.Based on disulfidptosis, unveiling the prognostic and immunological signatures of Asian hepatocellular carcinoma and identifying the potential therapeutic target ZNF337-AS1.
  Discov Oncol.2025 Apr 17;16(1):544.doi:10.1007/s12672-025-02325-5
  Shen, Duo (D);Sha, Ling (L);Yang, Ling (L);Gu, Xuefeng (X);
 
76.Unraveling the oncogenic role of LINC00504 and its interaction with miR-545-3p and ARIHI in hepatocellular carcinoma: novel insights for molecular therapy.
  Discov Oncol.2025 Apr 17;16(1):548.doi:10.1007/s12672-025-02328-2
  Ke, E (E);Yang, Kai (K);Zhang, Qin (Q);Luo, Cheng (C);Hu, Zhiyong (Z);Wang, Jing (J);Zhang, Hai (H);
 
77.The safety and efficacy of atezolizumab for recurrent primary liver cancer after liver transplantation.
  Discov Oncol.2025 Apr 17;16(1):553.doi:10.1007/s12672-025-02299-4
  Yao, Rong-Rong (RR);Zhang, Quan-Bao (QB);Ge, Meng-Xi (MX);Li, Li (L);Li, Jing (J);Zhou, Xin-Li (XL);Wang, Zheng-Xin (ZX);Liang, Xiao-Hua (XH);
 
78.Social Risk Factor Domains and Dementia in Medicare Beneficiaries Over 65 (P6-3.007).
  Neurology.2025 Apr 07;104(7_Supplement_1):2470.doi:10.1212/WNL.0000000000210362
  Yang, Winni (W);Yarsky, Eva (E);Venkataraman, Hariharan (H);Barros, Levi Coelho Maia (LCM);Feinstein, Erin (E);Hillen, Machteld (M);
 
79.E2F1-driven EXOSC10 transcription promotes hepatocellular carcinoma growth and stemness: a potential therapeutic target.
  Hereditas.2025 Apr 12;162(1):60.doi:10.1186/s41065-025-00430-7
  Deng, Haoyue (H);Wu, Dingyong (D);He, Yongpeng (Y);Yu, Xiaolei (X);Liu, Jifei (J);Zhang, Yanrui (Y);Leng, Bing (B);Yuan, Xiaofeng (X);Xiao, Liguo (L);
 
80.Health-related quality of life and survival of patients with hepatocellular carcinoma treated with transarterial chemoembolization and Yttrium-90.
  J Egypt Natl Canc Inst.2025 Apr 14;37(1):11.doi:10.1186/s43046-025-00267-1
  Bress, Kathryn (K);Bou-Samra, Patrick (P);Kallem, Cramer J (CJ);Tsung, Allan (A);Gammer, Ellie (E);Geller, David A (DA);Marsh, James W (JW);Steel, Jennifer L (JL);
 
81.BIRC2 blockade facilitates immunotherapy of hepatocellular carcinoma.
  Mol Cancer.2025 Apr 14;24(1):113.doi:10.1186/s12943-025-02319-5
  Fu, Lingyi (L);Li, Shuo (S);Mei, Jie (J);Li, Ziteng (Z);Yang, Xia (X);Zheng, Chengyou (C);Li, Nai (N);Lin, Yansong (Y);Cao, Chao (C);Liu, Lixuan (L);Huang, Liyun (L);Shen, Xiujiao (X);Huang, Yuhua (Y);Yun, Jingping (J);
 
82.Multiparametric MRI-based radiomics and clinical nomogram predicts the recurrence of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization.
  BMC Cancer.2025 Apr 14;25(1):683.doi:10.1186/s12885-025-14079-y
  Guo, Xinyu (X);Song, Jingjing (J);Zhu, Lingyi (L);Liu, Shuang (S);Huang, Chaoming (C);Zhou, Lingling (L);Chen, Weiyue (W);Lin, Guihan (G);Zhao, Zhongwei (Z);Tu, Jianfei (J);Chen, Minjiang (M);Chen, Feng (F);Zheng, Liyun (L);Ji, Jiansong (J);
 
83.FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure.
  Open Forum Infect Dis.2025 Apr 08;12(4):ofae628.doi:10.1093/ofid/ofae628
  Corma-Gómez, Anaïs (A);Corona-Mata, Diana (D);Martín-Carmona, Jésica (J);Galindo, María José (MJ);Camacho, Angela (A);Martín-Sierra, Carmen (C);Gallo-Marín, Marina (M);Rincón, Pilar (P);Perez-Valero, Ignacio (I);Pérez-García, Margarita (M);Carrasco-Dorado, Angela (A);Pineda, Juan A (JA);Rivero-Juárez, Antonio (A);Rivero, Antonio (A);Real, Luis M (LM);Macías, Juan (J);
 
84.Construction of a sensitive index system for nursing quality in the perioperative period of liver transplantation based on the Three-Dimensional Quality Structure theory.
  BMC Health Serv Res.2025 Apr 08;25(1):510.doi:10.1186/s12913-025-12676-y
  Wang, Bin (B);Sun, Wenjuan (W);Liu, Fengchao (F);Zheng, Taohua (T);Quan, Lin (L);Liu, Guofang (G);Lin, Hui (H);Qiao, Yue (Y);Cai, Jinzhen (J);Huang, Xia (X);
 
85.A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021.
  Cancer Innov.2025 Apr 07;4(3):e70006.doi:10.1002/cai2.70006
  Zhao, Hong (H);Mao, Yilei (Y);Wang, Hongguang (H);Zhou, Aiping (A);Yang, Zhengqiang (Z);Han, Yue (Y);Li, Gong (G);Bi, Xinyu (X);Hao, Chunyi (C);Wang, Xiaodong (X);Zhou, Jun (J);Dai, Chaoliu (C);Wen, Feng (F);Zhang, Jingdong (J);Liu, Ruibao (R);Li, Tao (T);Zhao, Lei (L);Niu, Zuoxing (Z);Wen, Tianfu (T);Li, Qiu (Q);Zhang, Hongmei (H);Chen, Xiaoming (X);Chen, Minshan (M);Zhao, Ming (M);Chen, Yajin (Y);Yu, Jun (J);Shen, Jie (J);Li, Xiangchen (X);Liu, Lianxin (L);Huang, Zhiyong (Z);Zhang, Wei (W);Shen, Feng (F);Zhou, Weiping (W);Yuan, Zhengang (Z);Zhai, Jian (J);Ge, Ningling (N);Chen, Yongjun (Y);Sun, Huichuan (H);Cai, Jianqiang (J);
 
86.Comorbidity in Midlife and Cancer Outcomes.
  JAMA Netw Open.2025 Apr 01;8(4):e253469.doi:10.1001/jamanetworkopen.2025.3469
  Lavery, Jessica A (JA);Boutros, Paul C (PC);Moskowitz, Chaya S (CS);Jones, Lee W (LW);
 
87.Colon cancer exosome-associated HSP90B1 initiates pre-metastatic niche formation in the liver by polarizing M1 macrophage into M2 phenotype.
  Biol Direct.2025 Apr 15;20(1):52.doi:10.1186/s13062-025-00623-0
  Li, ShuJie (S);Fu, Xue (X);Ning, Deng (D);Liu, QiuMeng (Q);Zhao, JunFang (J);Cheng, Qi (Q);Chen, XiaoPing (X);Jiang, Li (L);
 
88.Transient intracellular expression of PD-L1 and VEGFR2 bispecific nanobody in cancer cells inspires long-term T cell activation and infiltration to combat tumor and inhibit cancer metastasis.
  Mol Cancer.2025 Apr 19;24(1):119.doi:10.1186/s12943-025-02253-6
  Zhang, Lei (L);Lin, Yunfeng (Y);Hu, Li (L);Wang, Yanan (Y);Hu, Chaohua (C);Shangguan, Xinyi (X);Tang, Shuzhi (S);Chen, Jincan (J);Hu, Ping (P);Chen, Zhe-Sheng (ZS);Ke, Zun-Fu (ZF);Chen, Zhuo (Z);
 
89.Prognostic analysis of patients with CRLM based on CRS score: a single-center retrospective study.
  BMC Cancer.2025 Apr 17;25(1):718.doi:10.1186/s12885-025-14135-7
  Xue, Jun-Shuai (JS);Maimaitiming, Nuersimanguli (N);Zhang, Bo-Lun (BL);Xu, Bo-Wen (BW);Yin, Xin (X);Huang, Zhen (Z);Che, Xu (X);Zhao, Hong (H);Cai, Jian-Qiang (JQ);
 
90.Intrahepatic cholangiocarcinoma patient with epidermal growth factor receptor exon 19 deletion unresponsive to Afatinib monotherapy: a case report.
  Discov Oncol.2025 Apr 10;16(1):503.doi:10.1007/s12672-025-02271-2
  Deng, Caijiu (C);Huang, Junming (J);Yu, Qian (Q);Han, Jianjun (J);Jiang, Yuanxue (Y);Lin, Liping (L);Cao, Xiaolong (X);
 
91.AI-augmented reconstruction provides improved image quality and enables shorter breath-holds in contrast-enhanced liver MRI.
  Eur Radiol Exp.2025 May 01;9(1):46.doi:10.1186/s41747-025-00582-1
  Castagnoli, Francesca (F);Rata, Mihaela (M);Shur, Joshua (J);Hopkinson, Georgina (G);Macdonald, Alison (A);Stockton, David (D);Nickel, Marcel Dominik (MD);Kannengiesser, Stephan (S);Messiou, Christina (C);Koh, Dow-Mu (DM);Winfield, Jessica Mary (JM);
 
92.Causal associations between iron deficiency anemia and digestive system cancers: evidence from a bidirectional two-sample Mendelian randomization study.
  Discov Oncol.2025 May 01;16(1):650.doi:10.1007/s12672-025-02367-9
  Qin, Yan (Y);Zhou, Rong (R);
 
93.Venous thromboembolism in patients undergoing pancreatic cancer surgery (PaTR-VTE) with curative intent; protocol of a prospective observational study.
  BMC Surg.2025 Apr 26;25(1):183.doi:10.1186/s12893-024-02665-z
  Ntalouka, Maria P (MP);Symeonidis, Dimitrios (D);Kotsi, Paraskevi (P);Petinaki, Efthymia (E);Matsagkas, Miltiadis (M);Tepetes, Konstantinos (K);Zacharoulis, Dimitrios (D);Arnaoutoglou, Eleni M (EM);
 
94.PROtective ileoStomy versus ProtectivE colostomy in anterior Rectal resectIon: study protocol for a multicenter, open-label, randomised conTrolled studY (PROSPERITY).
  BMJ Open.2025 May 06;15(5):e096091.doi:10.1136/bmjopen-2024-096091
  Koskenvuo, Laura (L);Paajanen, Paavo (P);Varpe, Pirita (P);Seppälä, Toni (T);Mentula, Panu (P);Haapamäki, Carola (C);Carpelan-Holmström, Monika (M);Carpelan, Anu (A);Lehto, Kirsi (K);Satokari, Reetta (R);Lepistö, Anna (A);Sallinen, Ville (V);
 
95.Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study.
  ESMO Open.2025 May 16;10(6):105105.doi:10.1016/j.esmoop.2025.105105
  Decker, T (T);Brucker, C (C);Engel, A (A);Fasching, P A (PA);Göhler, T (T);Jackisch, C (C);Janssen, J (J);Köhler, A (A);Lüdtke-Heckenkamp, K (K);Lüftner, D (D);Marmé, F (F);van Mackelenbergh, M (M);Rautenberg, B (B);Schmidt, M (M);Weide, R (R);Wimberger, P (P);Kisseleff, E (E);Pfister, C (C);Roos, C (C);Wilhelm, N (N);Wöckel, A (A);
 
96.First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab, in patients with advanced malignancies.
  ESMO Open.2025 May 16;10(6):105051.doi:10.1016/j.esmoop.2025.105051
  Janku, F (F);Tan, D S P (DSP);Martin-Liberal, J (J);Takahashi, S (S);Geva, R (R);Gucalp, A (A);Razak, A (A);Kan, R (R);Reiners, R (R);Mataraza, J (J);Szpakowski, S (S);Subramanian, K (K);Chen, X (X);Lai, C (C);Bedard, P L (PL);
 
97.Patient experiences and expectations of faecal immunochemical testing for investigation of colorectal cancer symptoms: a cross-sectional qualitative interview study with patients and practitioners in the UK.
  BMJ Open.2025 May 16;15(5):e093215.doi:10.1136/bmjopen-2024-093215
  Biran, Adam (A);Dobson, Christina (C);Rees, Colin J (CJ);Hamilton, Willie (W);Humes, David (D);Neilson, Laura Jane (LJ);Turvill, James (J);von Wagner, Christian (C);Whelpton, John (J);Sharp, Linda (L);
 
98.Single-cell transcriptomic analysis deciphers the inflammatory microenvironment characterized by CXCL9+?fibroblasts and ACKR1+?endothelial cells in immune-related myocarditis.
  J Transl Med.2025 May 16;23(1):555.doi:10.1186/s12967-025-06551-x
  Sun, Boyu (B);Xun, Ziyu (Z);Zhou, Zixiang (Z);Zhang, Nan (N);Piao, Mingjian (M);Li, Chengjie (C);Li, Jiongyuan (J);Li, Shuofeng (S);Zhang, Longhao (L);Chen, Xiangqi (X);Wang, Hanping (H);Zhao, Haitao (H);
 
99.Geometric and dosimetric impact of inter-professional contour variability in the upper abdomen for MR-linac.
  J Med Imaging Radiat Sci.2025 May 13;56(5):101980.doi:10.1016/j.jmir.2025.101980
  Shessel, A (A);Velec, M (M);Liu, Z A (ZA);Moreira, A (A);Dang, J (J);Hosni, A (A);Lukovic, J (J);Appleyard, R M (RM);Rosewall, T (T);
 
100.Prediction models based on machine learning algorithms for COVID-19 severity risk.
  BMC Public Health.2025 May 13;25(1):1748.doi:10.1186/s12889-025-22976-x
  Zhang, Hansong (H);Wang, Ying (Y);Xie, Yan (Y);Wang, Cuihan (C);Ma, Yuqi (Y);Jin, Xin (X);
 
101.Preoperative plasma cell-free DNA chromosomal instability predicts microvascular invasion in hepatocellular carcinoma: a prospective study.
  BMC Cancer.2025 May 13;25(1):867.doi:10.1186/s12885-025-14268-9
  Shu, Zheyue (Z);Ye, Ting (T);Wu, Wei (W);Su, Menghan (M);Wang, Jingcheng (J);Zhang, Min (M);Qian, Ziliang (Z);Huang, Haifen (H);Zheng, Shusen (S);Xia, Qi (Q);
 
102.Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicenter prospective trial - trial protocol.
  BMC Surg.2025 May 13;25(1):204.doi:10.1186/s12893-025-02938-1
  Abreu de Carvalho, Luís Filipe (LF);Gryspeerdt, Filip (F);Ceelen, Wim (W);Geboes, Karen (K);Ribeiro, Suzane (S);Hoorens, Anne (A);Vandenbussche, Nele (N);Claes, Kathleen B M (KBM);Lecluyse, Clarisse (C);Anisau, Aliaksandr (A);Van Ongeval, Johan (J);Lybaert, Willem (W);Triest, Lars (L);Vervaecke, Andrew (A);Sas, Steven (S);Claerhout, Barbara (B);Beyls, Carolien (C);Sie, Mark (M);Berrevoet, Frederik (F);
 
103.A new selenium nanomaterial: structural insights, nonlinear optical properties (DFT study), and biological potential.
  J Mol Model.2025 May 19;31(6):160.doi:10.1007/s00894-025-06387-8
  Yankova, Rumyana (R);Yotova, Tsvetelina (T);Avramov, Mario (M);Benkova, Daiana (D);Dimov, Dimitar (D);Kostadinova, Aneliya (A);Markov, Pavel (P);
 
104.Chronic Kidney Disease or Hypertension After Childhood Cancer.
  JAMA Netw Open.2025 May 01;8(5):e258199.doi:10.1001/jamanetworkopen.2025.8199
  Lebel, Asaf (A);Chanchlani, Rahul (R);Cockovski, Vedran (V);Dart, Allison (A);Fleming, Adam James (AJ);Garg, Amit X (AX);Jeyakumar, Nivethika (N);Kim, Kirby (K);Kitchlu, Abhijat (A);McArthur, Eric (E);Nash, Danielle (D);Nathan, Paul C (PC);Parekh, Rulan S (RS);Pearl, Rachel (R);Pole, Jason (J);Ramphal, Raveena (R);Reid, Jennifer (J);Schechter-Finkelstein, Tal (T);Sung, Lillian (L);Wald, Ron (R);Wang, Stella (S);Wong, Peter (P);Zappitelli, Michael (M);
 
105.Preparation and preclinical evaluation of F-labeled folate-RGD peptide conjugate for PET imaging of triple-negative breast carcinoma.
  EJNMMI Radiopharm Chem.2025 May 19;10(1):25.doi:10.1186/s41181-025-00349-4
  Okarvi, Subhani M (SM);Maliki, Yousef (Y);
 
106.Deep learning models based on multiparametric magnetic resonance imaging and clinical parameters for identifying synchronous liver metastases from rectal cancer.
  BMC Med Imaging.2025 May 19;25(1):173.doi:10.1186/s12880-025-01692-3
  Sun, Jing (J);Wu, Pu-Yeh (PY);Shen, Fangmin (F);Chen, Xingfa (X);She, Jieqiong (J);Luo, Mingcong (M);Feng, Feifei (F);Zheng, Dechun (D);
 
107.Association of individual and community-level socioeconomic status and education with medication use: a multilevel analysis in the PERSIAN cohort.
  BMC Public Health.2025 May 19;25(1):1842.doi:10.1186/s12889-025-23062-y
  Akbari, Mohammadreza (M);Poustchi, Hossein (H);Taherifard, Erfan (E);Mehrian, Seyed Reza Abdipour (SRA);Rahimian, Zahra (Z);Mesgarpour, Bita (B);Pourfarzi, Farhad (F);Gharekhani, Afshin (A);Nejatizadeh, Azim (A);Moradpour, Farhad (F);Piraie, Elahe (E);Fakhraei, Bahareh (B);Joukar, Farahnaz (F);Saki, Nader (N);Safarpour, Ali Reza (AR);Moradinazar, Mehdi (M);Rezaianzadeh, Abbas (A);Tafaghodi, Mohsen (M);Esmaeili-Nadimi, Ali (A);Moslem, Alireza (A);Alijanvand, Moluk Hadi (MH);Moosazadeh, Mahmood (M);Mehrparvar, Amir Houshang (AH);Ansari-Moghaddam, Alireza (A);Taherifard, Ehsan (E);Ghahramani, SaharNaz (S);Pakroo, Mahsa (M);Mohammadi, Zahra (Z);Malekzadeh, Reza (R);Vardanjani, Hossein Molavi (HM);
 
108.Prognostic nutritional index predicts survival in intermediate and advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy combined with PD-(L)1 inhibitors and molecular targeted therapies.
  BMC Cancer.2025 Apr 03;25(1):603.doi:10.1186/s12885-025-13993-5
  Tang, Hao-Huan (HH);Zhang, Ming-Qing (MQ);Zhang, Zi-Chen (ZC);Fan, Chen (C);Li, Shu-Shu (SS);Chen, Wei (W);Wang, Wei-Dong (WD);
 
109.Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study.
  BMC Cancer.2025 Apr 03;25(1):602.doi:10.1186/s12885-025-13978-4
  Xu, Jun (J);Li, Junjun (J);Wang, Tengfei (T);Luo, Xin (X);Zhu, Zhangxiang (Z);Wang, Yimou (Y);Wang, Yong (Y);Zhang, Zhenglin (Z);Song, Ruipeng (R);Yang, Li-Zhuang (LZ);Wang, Hongzhi (H);Wong, Stephen T C (STC);Li, Hai (H);
 
110.The double-edged sword: impact of antibiotic use on immunotherapy efficacy in advanced hepatocellular carcinoma.
  BMC Gastroenterol.2025 Apr 04;25(1):221.doi:10.1186/s12876-025-03819-w
  Li, Yang (Y);Feng, Ziwei (Z);Liang, Canhua (C);Lu, Shaohuan (S);Wang, GuangZhao (G);Meng, Guangyi (G);
 
111.CCR8 antagonist suppresses liver cancer progression via turning tumor-infiltrating Tregs into less immunosuppressive phenotype.
  J Exp Clin Cancer Res.2025 Apr 04;44(1):113.doi:10.1186/s13046-025-03286-x
  Tian, Binle (B);Wang, Zhilong (Z);Cao, Mei (M);Wang, Na (N);Jia, Xuebing (X);Zhang, Yuanyuan (Y);Zhou, Jingyi (J);Liu, Sijia (S);Zhang, Wen (W);Dong, Xiao (X);Li, Zheng (Z);Xue, Junli (J);Wang, JianFei (J);Fan, Guo-Huang (GH);Li, Qi (Q);
 
112.Transfer learning improves performance in volumetric electron microscopy organelle segmentation across tissues.
  Bioinform Adv.2025 Apr 02;5(1):vbaf021.doi:10.1093/bioadv/vbaf021
  Xie, Ronald (R);Mulcahy, Ben (B);Darbandi, Ali (A);Marwah, Sagar (S);Ali, Fez (F);Lee, Yuna (Y);Parlakgul, Gunes (G);Hotamisligil, Gokhan S (GS);Wang, Bo (B);MacParland, Sonya (S);Zhen, Mei (M);Bader, Gary D (GD);
 
113.Low Intrahepatic Distant Recurrence Rate Following RFA Using Linear Mode in Patients With Hepatocellular Carcinoma.
  JGH Open.2025 Apr 01;9(4):e70145.doi:10.1002/jgh3.70145
  Takaya, Hiroaki (H);Namisaki, Tadashi (T);Komeda, Yusuke (Y);Kinoshita, Hiroki (H);Nishimura, Naoki (N);Tsuji, Yuki (Y);Sato, Shinya (S);Nishimura, Norihisa (N);Saito, Ko (K);Aizawa, Shigeyuki (S);Morioka, Chie (C);Noguchi, Ryuichi (R);Yoshida, Motoyuki (M);Kaji, Kosuke (K);Yoshiji, Hitoshi (H);
 
114.Identification of CCDC58 as a potential predictive biomarker of immune cell infiltration in hepatocellular carcinoma.
  Discov Oncol.2025 Apr 02;16(1):448.doi:10.1007/s12672-025-02185-z
  Liu, Zishen (Z);Lin, Xiaotong (X);Tan, Tingting (T);Xie, Guozhu (G);Chen, Ying (Y);
 
115.Association between allopurinol and hepatocellular carcinoma: analysis of genetic risk and patient survival.
  Discov Oncol.2025 Apr 02;16(1):454.doi:10.1007/s12672-025-02176-0
  Li, Yu-Fu (YF);Wang, Hui-Wei (HW);Peng, Huan-Yan (HY);Zhang, Zhen-Ying (ZY);Yao, Zhi-Jia (ZJ);Meng, Yuan (Y);Yang, Dong-Ye (DY);
 
116.Comprehensive molecular characteristics of hepatocellular carcinoma based on multi-omics analysis.
  BMC Cancer.2025 Mar 30;25(1):573.doi:10.1186/s12885-025-13952-0
  Wang, Ying-Ying (YY);Yang, Wan-Xia (WX);Cai, Jiang-Ying (JY);Wang, Fang-Fang (FF);You, Chong-Ge (CG);
 
117.Nucleolin as a Potent Biomarker for Predicting Tumor Recurrence among Patients with Hepatocellular Carcinoma after Transplantation.
  J Gastrointestin Liver Dis.2025 Mar 28;34(1):81-89.doi:10.15403/jgld-5873
  Chen, Guanrong (G);Hu, Xin (X);Huang, Yingchen (Y);Li, Huigang (H);Dong, Libin (L);Jiang, Yao (Y);Lu, Di (D);Jiang, Feng (F);Li, Xiuyang (X);Sun, Beicheng (B);Zheng, Shusen (S);Lang, Ren (R);Xu, Xiao (X);Chen, Ronggao (R);
 
118.ERCC3 serves as a prognostic biomarker for hepatocellular carcinoma and positively regulates cell proliferation and migration.
  Discov Oncol.2025 Mar 28;16(1):419.doi:10.1007/s12672-025-02194-y
  Yang, Chen (C);Du, Jiahui (J);Qiu, Xiuqin (X);Jia, Changhong (C);Ding, Cunbao (C);Wu, Yijie (Y);Gao, Chaoxu (C);Wang, Weijie (W);Wang, Xiaojun (X);Liu, Song-Bai (SB);
 
119.PD-1 inhibitors improve the efficacy of transcatheter arterial chemoembolization combined with apatinib in advanced hepatocellular carcinoma: a meta-analysis and trial sequential analysis.
  BMC Cancer.2025 Mar 28;25(1):564.doi:10.1186/s12885-025-13932-4
  Yu, Jiahui (J);Yu, Jinxin (J);Chen, Yimiao (Y);Yang, Yuting (Y);Yi, Pengsheng (P);
 
120.Role of radiotherapy on long-term outcomes of patients with small cell lung cancer under different metastasis patterns.
  World J Surg Oncol.2025 Apr 07;23(1):125.doi:10.1186/s12957-025-03766-6
  Dong, Hui (H);Wang, Wei (W);
 
121.Iceball growth 3D simulation model based on finite element method for hepatic cryoablation planning.
  BMC Gastroenterol.2025 Apr 07;25(1):227.doi:10.1186/s12876-025-03817-y
  Li, Shengwei (S);Zhang, Yumeng (Y);Zhou, Fanyu (F);Xu, Sheng (S);Wang, Yufeng (Y);Cheng, Lin (L);Bie, Zhixin (Z);Li, Bin (B);Li, Xiao-Guang (XG);
 
122.Deubiquitination of DNM1L by USP3 triggers the development and metastasis of gallbladder carcinoma.
  Biol Direct.2025 Apr 07;20(1):47.doi:10.1186/s13062-025-00637-8
  Liang, Ruopeng (R);Zhang, Xiaoxue (X);Wu, Shitao (S);Liu, Jing (J);Zhai, Yunpeng (Y);Lin, Chaojie (C);Wang, Zhenya (Z);Zhang, Yi (Y);Chen, Hao (H);Zhu, Rongtao (R);
 
123.Prognosis of liver abscess in the intensive care unit (POLAIR), a multicentre observational study.
  Crit Care.2025 Apr 07;29(1):146.doi:10.1186/s13054-025-05376-w
  Le Goff, Marie (M);Martino, Frédéric (F);Rossi, Geoffrey (G);Toussaint, Aurélia (A);Moncomble, Elsa (E);Reuter, Danielle (D);Garret, Charlotte (C);Decavèle, Maxence (M);Fraissé, Megan (M);Herault, Antoine (A);Argaud, Laurent (L);Garçon, Pierre (P);Saccheri, Clément (C);Meunier, Juliette (J);Voriot, Guillaume (G);Cadoz, Cyril (C);Yvin, Élise (É);Laurent, Virginie (V);Calvet, Laure (L);de Montmollin, Etienne (E);Schmidt, Julien (J);Issa, Nahema (N);Leclerc, Maxime (M);Das, Vincent (V);Lemiale, Virginie (V);Mariotte, Éric (É);
 
124.Comparative efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors versus tyrosine kinase inhibitors and immune checkpoint inhibitors alone in advanced hepatocellular carcinoma: a systematic review and meta-analysis.
  World J Surg Oncol.2025 Apr 07;23(1):126.doi:10.1186/s12957-025-03788-0
  Tian, Hengyu (H);Wan, Chidan (C);
 
125.Surgical protocol of robotic liver resection using a two-surgeon technique (TAKUMI-3): a technical note and initial outcomes.
  World J Surg Oncol.2025 Apr 07;23(1):124.doi:10.1186/s12957-025-03785-3
  Takagi, Kosei (K);Fuji, Tomokazu (T);Yasui, Kazuya (K);Umeda, Yuzo (Y);Yamada, Motohiko (M);Nishiyama, Takeyoshi (T);Nagai, Yasuo (Y);Kanehira, Noriyuki (N);Fujiwara, Toshiyoshi (T);
 
126.Donafenib versus sorafenib in triple therapy for unresectable hepatocellular carcinoma: a propensity score-matched multicenter analysis.
  World J Surg Oncol.2025 Apr 12;23(1):143.doi:10.1186/s12957-025-03767-5
  Wen, Yaohong (Y);Zhou, Shuyi (S);Xu, Yuyan (Y);Zhang, Cheng (C);Feng, Zhoubin (Z);Song, Yinghui (Y);Ding, Bai (B);Peng, Chuang (C);Tan, Hongkun (H);Wang, Chunming (C);Feng, Jianan (J);Pei, Jingyuan (J);He, Guolin (G);Fu, Shunjun (S);Wang, Lvhuan (L);Cai, Lei (L);Liu, Sulai (S);Pan, Mingxin (M);
 
127.Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use Disorder.
  Transplant Direct.2025 Mar 20;11(4):e1776.doi:10.1097/TXD.0000000000001776
  Meinders, Andrea M (AM);Connor, Ashton A (AA);Ontiveros, John (J);Elaileh, Ahmed (A);Patel, Khush (K);Todd, Jason (J);Nottage, Danika L (DL);Brombosz, Elizabeth W (EW);Moore, Linda W (LW);Simon, Caroline J (CJ);Cheah, Yee Lee (YL);Hobeika, Mark J (MJ);Mobley, Constance M (CM);Saharia, Ashish (A);Basra, Tamneet (T);Kodali, Sudha (S);Victor, David W (DW);Lee, Brian P (BP);Terrault, Norah (N);Li, Xian C (XC);Gaber, A Osama (AO);Ghobrial, R Mark (RM);
 
128.Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1.
  Cancer Cell Int.2025 Mar 19;25(1):104.doi:10.1186/s12935-025-03702-4
  Abolhasani, Shiva (S);Salehi Khesht, Armin Mahmoud (AM);Khodakarami, Atefeh (A);Masjedi, Ali (A);Rashidi, Bentolhoda (B);Izadi, Sepideh (S);Noukabadi, Fatemeh Karimian (FK);Karpisheh, Vahid (V);Poudeh, Khatereh Torabi (KT);Jalali, Pooya (P);Salehi, Zahra (Z);Bagherifar, Rafieh (R);Hejazian, Seyyed Sina (SS);Movassaghpour, AliAkbar (A);Feizi, Abbas Ali Hosseinpour (AAH);Jadidi, Farhad (F);
 
129.COPB2 promotes hepatocellular carcinoma progression through regulation of YAP1 nuclear translocation.
  Oncol Res.2025 Mar 19;33(4):975-988.doi:10.32604/or.2025.058085
  Wu, Biao (B);Guo, Xianlin (X);Wu, Zhishi (Z);Chen, Liang (L);Zhang, Suqing (S);
 
130.Insights into the history and trends of nanotechnology for the treatment of hepatocellular carcinoma: a bibliometric-based visual analysis.
  Discov Oncol.2025 Apr 07;16(1):484.doi:10.1007/s12672-025-02145-7
  Zhao, Yulei (Y);Wang, Xingxin (X);Yang, Xiaoman (X);Li, Jiaheng (J);Han, Bingbing (B);
 
131.SEPT9 and PAI-1 are immunohistochemical biomarkers of the hepatocellular carcinoma immune microenvironment.
  Discov Oncol.2025 Apr 07;16(1):483.doi:10.1007/s12672-025-02252-5
  Park, Eundong (E);Wang, Xin (X);Subasi, Nusret Bekir (NB);Kmeid, Michel (M);Higgins, Paul J (PJ);Chen, Anne (A);Lee, Hwajeong (H);
 
132.PET imaging of hepatocellular carcinoma with [I]IV-14.
  EJNMMI Res.2025 Apr 07;15(1):35.doi:10.1186/s13550-025-01227-5
  Cao, Wei (W);Sergeeva, Olga (O);Julian, William (W);Kresak, Adam (A);Lusinger, Destiny (D);Schneider, Joseph (J);Berridge, Marc S (MS);Sexton, Sandra (S);Wojtylak, Patrick (P);Li, Qiubai (Q);Liu, Wendy (W);Chan, Ernest Ricky (ER);Saunthararajah, Yogen (Y);Lee, Zhenghong (Z);
 
133.Role of the UNC13 Family in Human Diseases: A Literature Review (P9-2.003).
  Neurology.2025 Apr 07;104(7_Supplement_1):5847.doi:10.1212/WNL.0000000000212635
  Syed, Burhaan (B);Ansari, Ubaid (U);Chen, Vincent (V);Sedighi, Romteen (R);Muttalib, Zohaer (Z);Ansari, Khadija (K);Ansari, Fatima (F);Nadora, Denise (D);Razick, Daniel (D);Lui, Forshing (F);
 
134.Use of decision algorithms for viscoelastic tests and use of blood products in patients undergoing liver transplantation: A systematic review with meta-analysis.
  Transplant Rev (Orlando).2025 Apr 18;39(3):100932.doi:10.1016/j.trre.2025.100932
  de Oliveira Júnior, Gilvandro Lins (GL);Lins, Viviane Maria Bezerra Cavalcanti (VMBC);Cavalcanti, Virgínia Maria Bezerra (VMB);Tustumi, Francisco (F);Virgílio, Cassio (C);Andraus, Wellington (W);
 
135.Spatial distribution of fractionally administered holmium microspheres in non-tumorous human liver tissue: how livers survive transarterial radioembolisation.
  EJNMMI Res.2025 Apr 28;15(1):49.doi:10.1186/s13550-025-01240-8
  van den Brekel, Anne (A);Snoeijink, Tess J (TJ);de Meijer, Vincent E (VE);Boswinkel, Milou (M);de Jong, Koert P (KP);Roosen, Joey (J);Arranja, Alexandra G (AG);Fütterer, Jurgen J (JJ);Ruiter, Simeon J S (SJS);Nijsen, J Frank W (JFW);
 
136.LI-RADS-based hepatocellular carcinoma risk mapping using contrast-enhanced MRI and self-configuring deep learning.
  Cancer Imaging.2025 Mar 17;25(1):36.doi:10.1186/s40644-025-00844-6
  Stollmayer, Róbert (R);Güven, Selda (S);Heidt, Christian Marcel (CM);Schlamp, Kai (K);Kaposi, Pál Novák (PN);von Stackelberg, Oyunbileg (O);Kauczor, Hans-Ulrich (HU);Klauss, Miriam (M);Mayer, Philipp (P);
 
137.Gd-EOB-DTPA-enhanced MRI radiomics and deep learning models to predict microvascular invasion in hepatocellular carcinoma: a multicenter study.
  BMC Med Imaging.2025 Mar 31;25(1):105.doi:10.1186/s12880-025-01646-9
  Zhu, Zhu (Z);Wu, Kaiying (K);Lu, Jian (J);Dai, Sunxian (S);Xu, Dabo (D);Fang, Wei (W);Yu, Yixing (Y);Gu, Wenhao (W);
 
138.Diagnostic model using LI-RADS v2018 for predicting early recurrence of microvascular invasion-negative solitary hepatocellular carcinoma.
  Cancer Imaging.2025 Mar 31;25(1):46.doi:10.1186/s40644-025-00865-1
  Liang, Yingying (Y);Han, Xiaorui (X);Zhou, Tingwen (T);Xiao, Chuyin (C);Shi, Changzheng (C);Wei, Xinhua (X);Wu, Hongzhen (H);
 
139.Is total mesorectal excision mandatory in advanced ovarian cancer patients undergoing posterior pelvic exenteration? Prognostic role of mesorectal space involvement in a prospective ovarian cancer cohort.
  Eur J Surg Oncol.2025 Mar 06;51(7):109749.doi:10.1016/j.ejso.2025.109749
  Ferraioli, Domenico (D);Fuso, Luca (L);Chiadó, Francesca (F);Russo, Chiara (C);Rossi, Lea (L);Borella, Fulvio (F);Le Saux, Olivia (O);Ray-Coquard, Isabelle (I);Meeus, Pierre (P);Chopin, Nicolas (N);
 
140.Colorectal liver metastasis resection results in excellent long-term quality of life and low symptom burden.
  Eur J Surg Oncol.2025 Mar 06;51(7):109751.doi:10.1016/j.ejso.2025.109751
  Bhimani, Nazim (N);Dieng, Mbathio (M);Kelly, Patrick J (PJ);Hugh, Thomas J (TJ);
 
141.Fecal microbiota transplantation mitigates postdieting weight regain in mice by modulating the gut-liver axis.
  BMC Microbiol.2025 Mar 13;25(1):135.doi:10.1186/s12866-025-03853-4
  Cao, Hong (H);Xu, Jiangwei (J);Wang, Han (H);Yi, Wanya (W);Yang, Dandan (D);Yang, Ju (J);Sun, Jing (J);Wang, Yingyu (Y);Zhang, Feng (F);Yan, Jiai (J);Li, Dan (D);
 
142.Computed Tomography-Based Habitat Analysis for Prognostic Stratification in Colorectal Liver Metastases.
  Cancer Innov.2025 Mar 12;4(2):e70000.doi:10.1002/cai2.70000
  Zhou, Chaoqun (C);Xin, Hao (H);Qian, Lihua (L);Zhang, Yong (Y);Wang, Jing (J);Luo, Junpeng (J);
 
143.Identification of tumor immune infiltration-associated VPS72 and prognostic significance of VPS72 and CD8A in hepatocellular carcinoma.
  Discov Oncol.2025 Mar 27;16(1):410.doi:10.1007/s12672-025-02017-0
  Yang, Zhou (Z);Feng, Xiao (X);Yu, Haoyuan (H);Lv, Lei (L);Gao, Chengli (C);Liu, Wei (W);Yi, Shuhong (S);Jia, Changchang (C);Fu, Binsheng (B);
 
144.Deep learning empowered gadolinium-free contrast-enhanced abbreviated MRI for diagnosing hepatocellular carcinoma.
  JHEP Rep.2025 Mar 12;7(5):101392.doi:10.1016/j.jhepr.2025.101392
  Zhang, Yunfei (Y);Sheng, Ruofan (R);Qian, Xianling (X);Wang, Heqing (H);Wu, Fei (F);Dai, Haoran (H);Song, Mingyue (M);Yang, Chun (C);Zhou, Jianjun (J);Zhang, Weiguo (W);Zeng, Mengsu (M);
 
145.BUB1 serves as a biomarker for poor prognosis in liver hepatocellular carcinoma.
  BMC Immunol.2025 Mar 11;26(1):20.doi:10.1186/s12865-025-00698-4
  Zhang, Lili (L);Zhuge, Yuzheng (Y);Ni, Jingbin (J);
 
146.CGREF1 facilitates the cell proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of EIF3H/ Wnt/?-Catenin signaling axis.
  BMC Cancer.2025 Mar 11;25(1):435.doi:10.1186/s12885-025-13808-7
  Gao, Dongkai (D);Zhou, Zumo (Z);Chen, Lin (L);Zheng, Jun (J);Yang, Jinna (J);
 
147.CRSP8-driven fatty acid metabolism reprogramming enhances hepatocellular carcinoma progression by inhibiting RAN-mediated PPAR? nucleus-cytoplasm shuttling.
  J Exp Clin Cancer Res.2025 Mar 11;44(1):93.doi:10.1186/s13046-025-03329-3
  Lin, Yuxi (Y);Liang, Zhixing (Z);Weng, Zhiyan (Z);Liu, Xiaofang (X);Zhang, Feng (F);Chong, Yutian (Y);
 
148.SLC7A11, a disulfidptosis-related gene, correlates with multi-omics prognostic analysis in hepatocellular carcinoma.
  Eur J Med Res.2025 Mar 12;30(1):161.doi:10.1186/s40001-025-02411-y
  Li, Shizhe (S);Wang, Xiaotong (X);Xiao, Junbo (J);Yi, Jun (J);
 
149.Comprehensive Investigation of a Tyrosine Kinase Inhibitor-Resistant Gene in Hepatocellular Carcinoma.
  World J Oncol.2025 Mar 09;16(2):210-226.doi:10.14740/wjon2514
  Huang, Qing Ling (QL);Zhang, Guan Lan (GL);Su, Qin Yan (QY);Chi, Bang Teng (BT);Lin, Qian (Q);Li, Shi De (S);He, Han (H);Tang, Yu Lu (YL);Dang, Yi Wu (YW);Chen, Gang (G);He, Rong Quan (RQ);
 
150.CCL26 as a prognostic biomarker in hepatocellular carcinoma: integrating bioinformatics analysis, clinical validation, and radiomics score.
  Discov Oncol.2025 Apr 09;16(1):502.doi:10.1007/s12672-025-02280-1
  Yan, Junjun (J);Liao, Qiangming (Q);Xie, Yong (Y);Chen, Sihai (S);
 
151.Cuproplasia and cuproptosis in hepatocellular carcinoma: mechanisms, relationship and potential role in tumor microenvironment and treatment.
  Cancer Cell Int.2025 Apr 09;25(1):137.doi:10.1186/s12935-025-03683-4
  Zhang, Ruoyu (R);Tan, Yunfei (Y);Xu, Ke (K);Huang, Ning (N);Wang, Jian (J);Liu, Mei (M);Wang, Liming (L);
 
152.FIB-4 Index Can Predict Mortality in Hospitalized Patients with COVID-19 Infection, Independent of CT Severity Score.
  Arch Iran Med.2025 Feb 01;28(2):88-94.doi:10.34172/aim.33514
  Salahshour, Faeze (F);Karimpour Reyhan, Sahar (S);Zendedel, Kazem (K);Seifouri, Kiana (K);Seyyedsalehi, Monireh Sadat (MS);Naghavi, Parnian (P);Abbaszadeh, Mahsa (M);Esteghamati, Alireza (A);Nakhjavani, Manouchehr (M);Rabizadeh, Soghra (S);
 
153.A content review of COVID-19-related apps used in Vietnam.
  J Infect Dev Ctries.2025 Feb 28;19(2):208-220.doi:10.3855/jidc.19329
  Tran, Linh (L);Cucé, Federica (F);Thanh An, Nguyen (N);Dila, Kadek Agus Surya (KAS);Nam, Nguyen Hai (NH);Cat, Doan Le Nguyet (DLN);Jun, Lee Wei (LW);Ansar, Farrukh (F);Abdallh, Fatima (F);Vo, Au (A);Huy, Nguyen Tien (NT);
 
154.Negative impact of chemotherapy on kinetic growth rate of the future liver remnant if applied following PVE or ALPPS.
  PLoS One.2025 Mar 07;20(3):e0307937.doi:10.1371/journal.pone.0307937
  Welcker, Klara (K);Schneider, Martin A (MA);Reese, Tim (T);Ehrenfeld, Andrea (A);Weilert, Hauke (H);Stang, Axel (A);Wohlmuth, Peter (P);Warnke, Mia-Maria (MM);Reiner, Carolin (C);von Hahn, Thomas (T);Oldhafer, Karl J (KJ);Mahnken, Andreas H (AH);Brüning, Roland (R);
 
155.Anatomic versus nonanatomic resection for intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
  Int J Surg.2025 Jan 01;111(1):1440-1453.doi:10.1097/JS9.0000000000002134
  Jiang, Chuang (C);Hou, Gui-Min (GM);Zhang, Zhi-Hong (ZH);Qiang, Ze-Yuan (ZY);Wang, Hai-Chuan (HC);Zhou, Jin (J);Zeng, Yong (Y);
 
156.Cell Therapy Using Anti-NKG2A Pretreated Natural Killer Cells in Patients with Hepatocellular Carcinoma.
  Adv Pharm Bull.2024 Dec 05;14(4):918-926.doi:10.34172/apb.43869
  Tavakoli, Shirin (S);Samareh-Salavati, Maryam (M);Abdolahi, Shahrokh (S);Verdi, Javad (J);Seyhoun, Iman (I);Vousooghi, Nasim (N);Vaezi, Mohammad (M);Ghaderi, Afshin (A);Ghavamzadeh, Ardeshir (A);Barkhordar, Maryam (M);Ahmadvand, Mohammad (M);
 
157.Oral intake of Hibiscus sabdariffa L. increased c-Myc and caspase-3 gene expression and altered microbial population in colon of BALB/c mice induced to preneoplastic lesions.
  Eur J Nutr.2025 Mar 05;64(3):109.doi:10.1007/s00394-025-03622-z
  Ladeira Bernardes, Andressa (A);Albuquerque Pereira, Mariana de Fátima (MF);Xisto Campos, Iasmim (I);Ávila, Larissa (L);Dos Santos Cruz, Bruna Cristina (BC);Duarte Villas Mishima, Marcella (M);Maciel Dos Santos Dias, Manoela (M);de Oliveira Mendes, Tiago Antônio (TA);Gouveia Peluzio, Maria do Carmo (MDC);
 
158.Third Liver Resection for Re-recurrent Hepatocellular Carcinoma: Assessment of the Prognostic Factors of Long-term Survival.
  Cancer Diagn Progn.2025 Mar 03;5(2):162-170.doi:10.21873/cdp.10426
  Kori, Mayuko (M);Shimada, Kei (K);Hashimoto, Takuya (T);
 
159.Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis
 

J Hepatol.?2025 Feb 26:S0168-8278(25)00084-4.?doi: 10.1016/j.jhep.2025.02.008.Online ahead of print. 

Pierre Nahon?1,?Clovis Lusivika-Nzinga?2,?Philippe Merle?3,?Fabien Zoulim?3,?Thomas Decaens?4,?Nathalie Ganne-Carrié?5,?Georges-Philippe Pageaux?6,?Vincent Leroy?7,?Laurent Alric?8,?Jean-Pierre Bronowicki?9,?Marc Bourlière?10,?Jérôme Gournay?11,?Albert Tran?12,?Stanislas Pol?13,?Philippe Mathurin?14,?Véronique Loustaud-Ratti?15,?Sophie Métivier?16,?Victor De Ledinghen?17,?Armand Abergel?18,?Dominique Thabut?19,?Louis D'Alteroche?20,?Mohammed Bouattour?21,?Tarik Asselah?21,?Denis Ouzan?22,?Paul Cales?23,?Olivier Chazouillères?24,?Moana Gelu-Simeon?25,?Dominique Roulot?26,?Jérôme Boursier?23,?Carole Cagnot?27,?Sonia Tamazirt?28,?Alina Pascale?28,?Samuel Nilusmas?2,?Maïté Lewin?29,?Marianne Ziol?30,?Fabrice Carrat?2,?Jean-Charles Duclos-Vallée?28;?ANRS CO12 CirVir, CO22 Hepather, and LICAVIR groups 
 
160.Metabolic Cause of Cirrhosis Is the Emerging Etiology for Primary Liver Cancer in the Asia-Oceania Region: Analysis of Global Burden of Disease (GBD) Study 2021
 

J Gastroenterol Hepatol.?2025 Feb 27.?doi: 10.1111/jgh.16922.?Online ahead of print. 

Suprabhat Giri?1,?Sushrut Ingawale?2,?Gaurav Khatana?3,?Prasanna Gore?4,?Dibya Lochan Praharaj?1,?Vincent Wai-Sun Wong?5?6,?Daniel Q Huang?7?8,?Amit Singhal?9,?Ashok Choudhury?10 
 
161.A nomogram for predicting the risk of liver metastasis in non-functional neuroendocrine neoplasms: A population-based study.
  Eur J Surg Oncol.2025 Feb 21;51(5):109708.doi:10.1016/j.ejso.2025.109708
  Liu, Zhipeng (Z);Yang, Faji (F);Hao, Yijie (Y);Jiang, Qirong (Q);Jiang, Yupeng (Y);Zhang, Shizhe (S);Zhang, Yisu (Y);Zheng, Qixuan (Q);Niu, Zheyu (Z);Zhu, Huaqiang (H);Zhou, Xu (X);Lu, Jun (J);Gao, Hengjun (H);
 
162.EDN1 facilitates cisplatin resistance of non-small cell lung cancer cells by regulating the TNF signaling pathway.
  World J Surg Oncol.2025 Mar 01;23(1):71.doi:10.1186/s12957-025-03692-7
  Zhen, Jie (J);Sun, Long (L);Ji, Li (L);Zhou, Shaochong (S);Cui, Yijin (Y);Li, Zhenwei (Z);
 
163.The Age-stratified Cost of Biliary Atresia: A MarketScan®-Based Cost Analysis.
  J Pediatr Surg.2025 Feb 18;60(5):162244.doi:10.1016/j.jpedsurg.2025.162244
  Kahan, Anastasia M (AM);Holley, Anna Gongjoo (AG);Horns, Joshua (J);Jaramillo, Catalina (C);Jensen, M Kyle (MK);Russell, Katie W (KW);Nelson, Richard E (RE);Brooke, Benjamin S (BS);Guthery, Stephen (S);Kastenberg, Zachary J (ZJ);
 
164.Assessing the Significance and Progression of Too Small to Characterize Lesions in Hepatic CT Scans of Patients With a Cancer History: A Two-Center Cross-Sectional Study.
  Health Sci Rep.2025 Mar 02;8(3):e70374.doi:10.1002/hsr2.70374
  Khoroushi, Farzaneh (F);Moeini, Mohammad (M);Jarahi, Lida (L);Hassannejad, Ehsan (E);Kharghani, Farnaz (F);Moodi Ghalibaf, AmirAli (A);
 
165.Endoscopic removal of proximally migrated pancreatic duct stents: a case series and literature review.
  Ann Gastroenterol.2025 Feb 28;38(2):230-236.doi:10.20524/aog.2025.0954
  Jayanna, Sachin Hosahally (SH);Bush, Nikhil (N);Sharma, Ravi (R);Gupta, Rajesh (R);Rana, Surinder Singh (SS);
 
166.Treatment patterns and outcomes in hepatocellular carcinoma: Real-world experience in Greece from the retrospective OPAL study.
  Ann Gastroenterol.2025 Feb 28;38(2):195-207.doi:10.20524/aog.2025.0950
  Koskinas, John (J);Pantzios, Spyridon (S);Deutsch, Melanie (M);Koullias, Emmanuel (E);Alexopoulou, Alexandra (A);Kranidioti, Hariklia (H);Michailidou, Elisavet (E);Goulis, Ioannis (I);Papagiouvanni, Ioanna (I);Koutroubakis, Ioannis (I);Samonakis, Dimitrios (D);Drygiannakis, Ioannis (I);Magafouraki, Eleni (E);Tsaliki, Evdokia (E);Manolakopoulos, Spilios (S);Elefsiniotis, Ioannis (I);Papatheodoridis, Georgios (G);
 
167.The Effect of Perioperative Fluid Therapy on Postoperative Renal Functions in Patients Receiving Liver Transplantation from Living Donors: A Retrospective Observational Study.
  Indian J Crit Care Med.2025 Feb 28;29(3):251-261.doi:10.5005/jp-journals-10071-24907
  K?z?lc?k, Nurcan (N);
 
168.A novel prognostic scoring model based on cuproptosis identifies COMMD1 as a novel therapy target for liver hepatocellular carcinoma.
  Oncol Res.2025 Feb 28;33(3):617-630.doi:10.32604/or.2024.049772
  Tian, K E (KE);Li, Zhipeng (Z);Zhai, Xiangyu (X);Zhou, Huaxin (H);Yao, Hui (H);
 
169. inhibits the malignant progression of hepatocellular carcinoma by inhibiting expression and epithelial-mesenchymal transition.
  Oncol Res.2025 Feb 28;33(3):709-722.doi:10.32604/or.2024.050125
  Jiang, Dong (D);Qi, Zhi (Z);Xu, Zhiying (Z);Li, Yiran (Y);
 
170.Scaffold implantation intravenous delivery: a comparative preclinical animal study evaluating peroxisome proliferator-activated receptor gamma coactivator 1-alpha adipose-derived stem cells in liver fibrosis treatment.
  Ann Surg Treat Res.2025 Feb 28;108(3):186-197.doi:10.4174/astr.2025.108.3.186
  Ahn, Joseph (J);Park, Jung Hyun (JH);Choi, Ho Joong (HJ);Lee, Dosang (D);Hong, Ha-Eun (HE);Kim, Ok-Hee (OH);Kim, Say-June (SJ);
 
171.Spleen volume after stage-I associated liver partition and portal vein ligation for staged hepatectomy predicts future liver remnant.
  Langenbecks Arch Surg.2025 Apr 15;410(1):128.doi:10.1007/s00423-025-03698-5
  Wang, Wei (W);Qin, Zhi (Z);Wang, Ji-Long (JL);Zhang, Ling (L);Xu, Bang-Hao (BH);Zhu, Hai (H);Guo, Ya (Y);Wen, Zhang (Z);
 
172.Knockdown of FANCI suppresses hepatocellular carcinoma development via the PI3K/Akt/GSK-3? pathway.
  Heliyon.2025 Feb 15;11(4):e42731.doi:10.1016/j.heliyon.2025.e42731
  Yin, Ziwei (Z);Lu, Minqiang (M);Fu, Rongdang (R);
 
173.Genomic and micro-environmental insights into drug resistance in colorectal cancer liver metastases.
  Discov Oncol.2025 Feb 26;16(1):241.doi:10.1007/s12672-025-01976-8
  Kuang, Junjie (J);Li, Jun (J);Zhou, Siwei (S);Li, Yi (Y);Lin, Jinbo (J);Huang, Weizhen (W);Yuan, Xia (X);
 
174.Long-term Outcomes of Surgical Treatment for Pancreatic Neuroendocrine Neoplasm With Synchronous Hepatic Metastasis: A Multicenter Retrospective Cohort Study.
  Pancreas.2024 Nov 18;54(3):e179-e187.doi:10.1097/MPA.0000000000002417
  Xu, Qiang (Q);Yin, Bohui (B);Han, Xu (X);Ren, Siqian (S);Jiang, Jialin (J);Li, Fang (F);Wijarnpreecha, Karn (K);Wang, Jingqiao (J);Liao, Quan (Q);Dai, Menghua (M);Zhang, Taiping (T);Sadula, Abuduhaibaier (A);Lou, Wenhui (W);Yuan, Chunhui (C);Wu, Wenming (W);Zhao, Yupei (Y);
 
175.Effect of conditioned medium from miRNA-34a transfected gastric cancer-associated fibroblast on peripheral blood mononuclear cells.
  BMC Immunol.2025 Feb 25;26(1):9.doi:10.1186/s12865-025-00688-6
  Esmaili, Mozhgan (M);Jafari, Narjes (N);Ahmadzadeh, Fatemeh (F);Toosi, Seyed Mohammad Valizadeh (SMV);Abediankenari, Saeid (S);
 
176.EIF4E-mediated biogenesis of circPHF14 promotes the growth and metastasis of pancreatic ductal adenocarcinoma via Wnt/?-catenin pathway.
  Mol Cancer.2025 Feb 26;24(1):56.doi:10.1186/s12943-025-02262-5
  Fang, Zhou (Z);Wu, Zhuo (Z);Yu, Chao (C);Xie, Qingyu (Q);Zeng, Liangtang (L);Chen, Rufu (R);
 
177.Multiple metabolic analysis of [F]FDG PET/CT in patients with kidney disease.
  Heliyon.2025 Feb 06;11(4):e42522.doi:10.1016/j.heliyon.2025.e42522
  Jiao, Hao (H);Qiu, Yongkang (Y);Chen, Zhao (Z);Zhang, Yongbai (Y);Huang, Wenpeng (W);Yang, Qi (Q);Kang, Lei (L);
 
178.Association of occupational physical activity and sedentary behaviour with the risk of hepatocellular carcinoma: a case-control study based on the Inpatient Clinico-Occupational Database of Rosai Hospital Group.
  BMJ Open.2025 Mar 12;15(3):e092020.doi:10.1136/bmjopen-2024-092020
  Nakazawa, Shoko (S);Fukai, Kota (K);Sano, Kei (K);Furuya, Yuko (Y);Hoshi, Keika (K);Kojimahara, Noriko (N);Toyota, Akihiro (A);Korenaga, Masaaki (M);Tatemichi, Masayuki (M);
 
179.Current insights into anaesthesia and critical care management of patients with hepatocellular carcinoma: Multifaceted implications for the anaesthesiologist and intensive care physician
 

Eur J Anaesthesiol.?2025 Feb 13.?doi: 10.1097/EJA.0000000000002141.?Online ahead of print. 

Antoine Monsel?1,?Alexandre Sitbon,?Charles Roux,?Daniel Eyraud,?Olivier Scatton,?Corinne Vezinet,?Marie-Virginie Oré,?Jérémy Gallet,?Mathilde Wagner,?Dominique Thabut,?Sarah Boughdad,?Florence Renaud,?Alessandra Mazzola,?Claire Goumard,?Manon Allaire;?Liver Institute of la Pitié-Salpêtrière (LIPS)—University Hospital in Paris 
 
180.Dedicated Automatic Recall Hepatocellular Cancer Surveillance Programme Demonstrates High Retention: A Population-Based Cohort Study
 

Liver Int.?2025 Mar;45(3):e70020.?doi: 10.1111/liv.70020. 

Mayur Brahmania?1?2,?Stephen Congly?1?2,?Yashasavi Sachar?3,?Kelly W Burak?1?4,?Brendan Lethebe?5,?Jessie Hart Szostakiwskyj?5,?David Lautner?6,?Alexandra Medellin?6,?Deepak Bhayana?6,?Jason Wong?6,?Henry Nguyen?1,?Matthew D Sadler?1,?Meredith Borman?1,?Alexander I Aspinall?1,?Carla S Coffin?1,?Mark Swain?1,?Abdel-Aziz Shaheen?1?2 
 
181.Etiology and Clinical Features of Secondary Sclerosing Cholangitis: A Single-Center Retrospective Study From 2016 to 2024.
  JGH Open.2025 Feb 21;9(2):e70122.doi:10.1002/jgh3.70122
  Meng, Xiangchen (X);Peng, Jiafei (J);Wei, Hongtao (H);
 
182.Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma.
  JAMA Netw Open.2025 Feb 03;8(2):e2461735.doi:10.1001/jamanetworkopen.2024.61735
  Lim, Mir (M);Espinoza, Magdalena (M);Huang, Yi-Hsiang (YH);Franses, Joseph (J);Zhu, Hao (H);Hsiehchen, David (D);
 
183.DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy
 

J Viral Hepat.?2025 Feb;32(2):e14056.?doi: 10.1111/jvh.14056. 

Amit G Singal?1,?K Rajender Reddy?2,?Massimo Colombo?3,?Heather L Morris?4,?Andrea R Mospan?4,?Roniel Cabrera?5,?Robin K Kelley?6,?Ryan D Kilpatrick?7,?Franco Trevisani?8,?Fabio Farinati?9,?Edoardo G Giannini?10,?Neil Mehta?6,?Michael W Fried?4,?Bruno Sangro?11;?DAA-PASS and ITA.LI.CA Investigators 
 
184.Disparities in Alcohol-Associated Liver Disease Hospital Encounters Amongst a Texas-Based Cohort of Patients
 

Aliment Pharmacol Ther.?2025 Jan 16.?doi: 10.1111/apt.18477.?Online ahead of print. 

Thomas G Cotter?1,?Ahmad Anouti?1,?Bill Zhang?2,?Elias D Rady?1,?Mausam Patel?2,?Suraj Patel?1,?Daniel J Ellis?1,?Sarah R Lieber?1,?Nicole E Rich?1,?Jacqueline G O'Leary?1,?Mack C Mitchell?1,?Amit G Singal?1 
 
185.Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
 

Lancet.?2025 Jan 18;405(10474):216-232.doi: 10.1016/S0140-6736(24)02551-0.?Epub 2025 Jan 8. 

Bruno Sangro?1,?Masatoshi Kudo?2,?Joseph P Erinjeri?3,?Shukui Qin?4,?Zhenggang Ren?5,?Stephen L Chan?6,?Yasuaki Arai?7,?Jeong Heo?8,?Anh Mai?9,?Jose Escobar?10,?Yamil Alonso Lopez Chuken?11,?Jung-Hwan Yoon?12,?Won Young Tak?13,?Valeriy V Breder?14,?Tanita Suttichaimongkol?15,?Mohamed Bouattour?16,?Shi-Ming Lin?17,?Jean-Marie Peron?18,?Quang T Nguyen?19,?Lunan Yan?20,?Chang-Fang Chiu?21,?Florinda A Santos?22,?Anil Veluvolu?23,?Satheesh Chiradoni Thungappa?24,?Marco Matos?25,?Magdalena Zotkiewicz?26,?Stephanie I Udoye?27,?John F Kurland?27,?Gordon J Cohen?27,?Riccardo Lencioni?28;?EMERALD-1 Investigators 

Collaborators 

EMERALD-1 Investigators:? 

Kathia Abdalla,?Manon Allaire,?Gustavo Alves,?Luis Antunes,?Eric Assenat,?Sergio Azevedo,?Rafael Barreto,?Muhammad Beg,?Glaucio Bertollo,?Jean-Frederic Blanc,?Mohamed Bouattour,?Rakesh Reddy Boya,?Valery Breder,?Jean-Pierre Bronowicki,?Manoch Buranachokphaisan,?Adam Burgoyne,?Stephen Chan,?Ting-Tsung Chang,?Yee Chao,?Eric Chen,?Xiaoming Chen,?Chang-Fang Chiu,?Minsig Choi,?Sunghee Choi,?Natalie Coburn,?Luis Contreras,?Farshid Dayyani,?Thomas Decaens,?Arunee Dechaphunkul,?Maria Del Consuelo Diaz,?Anouk Dev,?Jamille Dutra,?Melissa Eastgate,?Jose Escobar,?Bassam Estfan,?Vittorio Ferrari,?Anne-Claire Frin,?Sandip Ganguly,?Ranga Raman Ganta,?Shanzhi Gu,?Yabing Guo,?Atsushi Hagihara,?Jeong Heo,?Chih-Hung Hsu,?Jimmy Hwang,?Yoshitaka Inaba,?Shikha Jain,?Derek Jonker,?Rajeev L K,?Shruti Kate,?Naoya Kato,?Tomokazu Kawaoka,?Kwong-Ming Kee,?Seung Up Kim,?Kiyohide Kioka,?Hironori Koga,?Masatoshi Kudo,?Hidekatsu Kuroda,?Phuong Le,?Han-Chu Lee,?Joon Hyeok Lee,?Teng-Yu Lee,?Dongliang Li,?Hailiang Li,?Wei Li,?Xiao Li,?Cheng-Yao Lin,?Shi-Ming Lin,?Yamil Lopez,?Ligong Lu,?Anh Mai,?Konstantin Mamontov,?Kunlatida Maneenil,?Aleksei Manikhas,?Gianluca Masi,?Ana Maria Matilla,?Marco Matos,?Vincenzo Mazzaferro,?Zhiqiang Meng,?Prabrajya Narayan Mohapatra,?Vladimir Moiseyenko,?Alejandro Molina,?Jose Luis Montero,?Manabu Morimoto,?Daniel Motola,?Guzel Mukhametshina,?Hayato Nakagawa,?Jean-Charles Nault,?Quang Nguyen,?Amanda Nicoll,?Maria Noriega,?Takuji Okusaka,?Hideki Onishi,?Vikas Sureshchand Ostwal,?Jie Pan,?Joong-Won Park,?Ankit Patel,?Rodrigo Perez,?Jean-Marie Peron,?Shukui Qin,?Francisco Ramirez,?Zhenggang Ren,?Stuart Roberts,?Julie Rowe,?Yotsawaj Runglodvatana,?Bruno Sangro,?Florinda Santos,?Ravi Kumar Saxena,?Guoliang Shao,?Anthony Shields,?Oksana Shirokova,?Aditya Shreenivas,?Michele Sisani,?Vitalii Skoropad,?Simone Strasser,?Thatthan Suksombooncharoen,?Tanita Suttichaimongkol,?Wai Meng Tai,?Won Young Tak,?Gaojun Teng,?Satheesh Chiradoni Thungappa,?Nguyen Tran,?Son Trinh,?Kaoru Tsuchiya,?Kunihiko Tsuji,?Idoia Ugarteburu,?Teerapat Ungtrakul,?Gina Vaccaro,?Anil Veluvolu,?Truc Vo,?Yoshiyuki Wada,?Alva Weir,?Aibing Xu,?Lvnan Yan,?Jung-Hwan Yoon,?Oleg Zarubenkov,?Yongyi Zeng,?Yonghong Zhang,?Ming Zhao,?Xin Zheng,?Ling Zhu,?Xu Zhu 
 
186.County-Level Food Insecurity and Hepatocellular Carcinoma Risk: A Cross-Sectional Analysis
 

Int J Environ Res Public Health.?2025 Jan 18;22(1):120.?doi: 10.3390/ijerph22010120. 

Rebecca D Kehm?1?2,?Chrystelle L Vilfranc?2,?Jasmine A McDonald?1?2,?Hui-Chen Wu?2?3 
 
187.Synthesising enablers and barriers to hepatocellular carcinoma surveillance-A systematic review of qualitative findings
 

PLoS One.?2025 Jan 10;20(1):e0313216.?doi: 10.1371/journal.pone.0313216.?eCollection 2025. 

Dina Moussa?1?2?3,?Joan Ericka Flores?1?2,?Joseph S Doyle?3?4,?Marno Ryan?2,?Jack Wallace?3?5?6,?Jessica Howell?1?2?3 
 
188.Clinical Vignettes Illustrating the Spectrum of Hepatocellular Carcinoma Presentation and Treatment
 

Clin Liver Dis.?2025 Feb;29(1):125-133.?doi: 10.1016/j.cld.2024.08.011.Epub 2024 Oct 20. 

Jared Travers?1,?Amit Mahipal?2,?Pranit Chotai?3,?Pierre M Gholam?4 
 
189.EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
 

J Hepatol.?2025 Feb;82(2):315-374.?doi: 10.1016/j.jhep.2024.08.028.Epub 2024 Dec 17. 

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu;?European Association for the Study of the Liver 
 
190.Fecal Microbiota Transplantation for Refractory Infection Post Haploidentical Transplant for Pediatric Acute Myeloid Leukemia.
  Blood Cell Ther.2025 Feb 14;8(1):170-172.doi:10.31547/bct-2024-015
  Borah, Pronamee (P);Gautam, Vipul (V);Kumar, Vikram (V);Saikia, Bhaskar (B);Naithani, Rahul (R);
 
191.Unraveling the causal relationship and underlying mechanisms between cathepsins on liver cancer: findings from mendelian randomization and bioinformatics analysis.
  Discov Oncol.2025 Mar 07;16(1):277.doi:10.1007/s12672-025-02030-3
  Wang, Xiaoxue (X);Zhu, Zexin (Z);
 
192.CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma.
  Discov Oncol.2025 Mar 07;16(1):272.doi:10.1007/s12672-025-02051-y
  Yang, Liang (L);Li, Peiping (P);Zhao, JiaLi (J);Bai, Zirui (Z);Zeng, Guifang (G);Liu, Xialei (X);Zou, Baojia (B);Li, Jian (J);
 
193.DLAT activates EMT to promote HCC metastasis by regulating GLUT1-mediated aerobic glycolysis.
  Mol Med.2025 Feb 20;31(1):71.doi:10.1186/s10020-025-01125-5
  Yin, Qian (Q);Yao, Yinye (Y);Ni, Jiaojiao (J);Zhang, Yiwen (Y);Wu, Jia (J);Zeng, Hui (H);Wu, Wei (W);Zhuo, Wei (W);Ying, Jieer (J);Li, Jingjing (J);
 
194.Indocyanine Green Fluorescence Imaging for Intraoperative Confirmation of Bile Flow from Hilar Microbile Ducts during Kasai Portoenterostomy.
  J Indian Assoc Pediatr Surg.2025 Feb 20;30(2):220-224.doi:10.4103/jiaps.jiaps_231_24
  Jaseel, Muhammed (M);Vasudevan, Anu K (AK);Sihag, Abhinav (A);Shanmugam, Naresh (N);Sankaranarayanan, Srinivas (S);Rela, Mohamed (M);Ramachandran, Priya (P);
 
195.Noninvasive Monitoring of Intracranial Pressure in Patients with Acute Liver Failure Using Transcranial Doppler Ultrasonography: A Pilot Study (P9-7.008).
  Neurology.2025 Apr 07;104(7_Supplement_1):4970.doi:10.1212/WNL.0000000000212043
  Gutzwiller, Eveline (E);Jawed, Rafia (R);Duka, Leonidha (L);De Matteo, Céline (C);Temes, Richard (R);Blake, Stacey (S);Onwochei, Jennifer (J);
 
196.Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab-bevacizumab resistance and worse survival in advanced hepatocarcinoma.
  ESMO Open.2025 Mar 05;10(3):104289.doi:10.1016/j.esmoop.2025.104289
  Gramantieri, L (L);Montagner, A (A);Arleo, A (A);Suzzi, F (F);Bassi, C (C);Tovoli, F (F);Bruccoleri, M (M);Alimenti, E (E);Fornari, F (F);Iavarone, M (M);Negrini, M (M);Piscaglia, F (F);Giovannini, C (C);
 
197.Cost-effectiveness of atezolizumab plus bevacizumab versus sorafenib as first-line therapy in unresectable hepatocellular carcinoma in the US and Chinese setting: a modelling comparison study.
  BMJ Open.2025 Mar 06;15(3):e094804.doi:10.1136/bmjopen-2024-094804
  Liu, Lulu (L);Wang, Lei (L);Ding, Yiling (Y);Zhang, Qilin (Q);Shu, Yamin (Y);
 
198.FVTF inhibits hepatocellular carcinoma stem properties via targeting DNMT1/miR-34a-5p/FoxM1 axis.
  Chin Med.2025 Mar 06;20(1):32.doi:10.1186/s13020-025-01084-3
  Cao, Xiao-Cheng (XC);Peng, Jinwu (J);Qiu, Ye-Bei (YB);Zhu, Wei (W);Cao, Jian-Guo (JG);Zou, Hui (H);Yu, Zheng-Zheng (ZZ);Wu, Di (D);Lu, Shan-Shan (SS);Huang, Wei (W);Yi, Hong (H);Xiao, Zhi-Qiang (ZQ);
 
199.HCC-derived CX3CL1 affects hepatocellular carcinoma prognosis and CX3CR1?+?MDSC infiltration.
  Eur J Med Res.2025 Mar 06;30(1):153.doi:10.1186/s40001-025-02410-z
  Zhang, Xiaoling (X);Lou, Yidan (Y);Zheng, Song (S);Chang, Xu (X);
 
200.First-in-human clinical study of an embryonic stem cell product for urea cycle disorders.
  Stem Cell Res Ther.2025 Mar 06;16(1):120.doi:10.1186/s13287-025-04162-3
  Umezawa, Akihiro (A);Fukuda, Akinari (A);Horikawa, Reiko (R);Uchida, Hajime (H);Enosawa, Shin (S);Oishi, Yoshie (Y);Nakamura, Naoko (N);Sasaki, Kengo (K);Yanagi, Yusuke (Y);Shimizu, Seiichi (S);Nakao, Toshimasa (T);Kodama, Tasuku (T);Sakamoto, Seisuke (S);Hayakawa, Itaru (I);Akiyama, Saeko (S);Saku, Noriaki (N);Miyata, Shoko (S);Ite, Kenta (K);Javaregowda, Palaksha Kanive (PK);Toyoda, Masashi (M);Nonaka, Hidenori (H);Nakamura, Kazuaki (K);Ito, Yoshikazu (Y);Fukuhara, Yasuyuki (Y);Miyazaki, Osamu (O);Nosaka, Shunsuke (S);Nakabayashi, Kazuhiko (K);Haga, Chizuko (C);Yoshioka, Takako (T);Masuda, Akira (A);Ohkura, Takashi (T);Yamazaki-Inoue, Mayu (M);Machida, Masakazu (M);Abutani-Sakamoto, Rie (R);Miyajima, Shoko (S);Akutsu, Hidenori (H);Matsubara, Yoichi (Y);Igarashi, Takashi (T);Kasahara, Mureo (M);
 
201.Detecting the preoperative peripheral blood systemic immune-inflammation index (SII) as a tool for early diagnosis and prognosis of gallbladder cancer.
  BMC Immunol.2025 Feb 18;26(1):7.doi:10.1186/s12865-025-00683-x
  Liu, Feng (F);Yin, Pengyu (P);Jiao, Baoping (B);Shi, Zhiyong (Z);Qiao, Feifei (F);Xu, Jun (J);
 
202.Individual mHLA-DR trajectories in the ICU as predictors of early infections following liver transplantation: a prospective observational study.
  Crit Care.2025 Feb 18;29(1):79.doi:10.1186/s13054-025-05305-x
  Delignette, M C (MC);Riff, A (A);Antonini, T (T);Soustre, T (T);Bodinier, M (M);Peronnet, E (E);Venet, F (F);Gossez, M (M);Pantel, S (S);Mabrut, J Y (JY);Muller, X (X);Mohkam, K (K);Villeret, F (F);Erard, D (D);Dumortier, J (J);Zoulim, F (F);Heyer, L (L);Guichon, C (C);Blet, A (A);Aubrun, F (F);Monneret, G (G);Lebossé, F (F);
 
203.Undergraduate medical, health science, and technical students' attitudes and knowledge on organ donation and transplantation.
  BMC Med Educ.2025 May 18;25(1):722.doi:10.1186/s12909-025-07304-6
  Sinda, Ida (I);Lehto, Pasi (P);Koivusalo, Anna-Maria (AM);Sälkiö, Sinikka (S);Stauffer, Hilja-Maaria (HM);Ala-Kokko, Tero (T);
 
204.Towards fully automatized [177Lu]Lu-PSMA personalized dosimetry based on 360° CZT whole-body SPECT/CT: a proof-of-concept.
  EJNMMI Phys.2025 Mar 20;12(1):25.doi:10.1186/s40658-025-00727-6
  Dieudonné, Arnaud (A);Terro, Aya (A);Dumouchel, Arthur (A);Perret, Solène (S);Edet-Sanson, Agathe (A);Vera, Pierre (P);Hapdey, Sébastien (S);Modzelewski, Romain (R);Tonnelet, David (D);Decazes, Pierre (P);
 
205.Hematological toxicity of [Ac]Ac-PSMA-617 and [Lu]Lu-PSMA-617 in RM1-PGLS syngeneic mouse model.
  EJNMMI Radiopharm Chem.2025 Mar 24;10(1):12.doi:10.1186/s41181-025-00333-y
  Vilangattil, Meryl Maria (MM);Swaidan, Abir (A);Godinez, Jonathan (J);Taddio, Marco F (MF);Czernin, Johannes (J);Mona, Christine E (CE);Carlucci, Giuseppe (G);
 
206.Hepatobiliary phase manifestations of breast cancer liver metastasis: differentiating molecular types through Gd-EOB-DTPA-enhanced MRI.
  BMC Med Imaging.2025 Mar 28;25(1):104.doi:10.1186/s12880-025-01648-7
  Jiang, Hui (H);Qu, Jin-Rong (JR);Wang, Li-Feng (LF);Gao, Peng-Rui (PR);Zheng, Bing-Jie (BJ);Zhang, Hong-Kai (HK);Jiang, Li-Na (LN);
 
207.Association of SLCO1B1 genetic variants with neonatal hyperbilirubinemia: a consolidated analysis of 36 studies.
  BMC Pediatr.2025 Mar 28;25(1):251.doi:10.1186/s12887-025-05493-z
  Talebi, Hanieh (H);Dastgheib, Seyed Alireza (SA);Vafapour, Maryam (M);Bahrami, Reza (R);Shahbazi, Amirhossein (A);Shams, Seyedeh Elham (SE);Danaei, Mahsa (M);Rashnavadi, Heewa (H);Yeganegi, Maryam (M);Pourkazemi, Melina (M);Shiri, Amirmasoud (A);Aghasipour, Maryam (M);Neamatzadeh, Hossein (H);
 
208.Impact of negative lymph node removal on survival in esophageal cancer: a systematic review and meta-analysis.
  BMC Surg.2025 Mar 28;25(1):124.doi:10.1186/s12893-025-02858-0
  Bahardoust, Mansour (M);Torabi, Seyedmohammadreza (S);Yarahmadi, Danyal (D);Kakoienejad, Mohammad Mahdi (MM);Abbasi, Fatemeh (F);Shamohammadi, Mohammadsadra (M);Haghmoradi, Meisam (M);Goodarzy, Babak (B);Tizmaghz, Adnan (A);
 
209.Survival Outcomes in Nonmetastatic pT4 Pancreatic Ductal Adenocarcinoma: A SEER Database Analysis Comparing Neoadjuvant Therapy and Upfront Surgery with Propensity Score Matching.
  Asian Pac J Cancer Prev.2025 Mar 01;26(3):847-859.doi:10.31557/APJCP.2025.26.3.847
  Zhao, Yun (Y);Goh, Brian Kim Poh (BKP);Chok, Aik Yong (AY);Koh, Ye Xin (YX);
 
210.Key prognostic factors in transarterial chemoembolization combined with sorafenib treatment for hepatocellular carcinoma with portal vein tumor thrombosis.
  Am J Cancer Res.2025 Feb 15;15(2):517-532.doi:10.62347/SXMJ5155
  Lei, Zilun (Z);Chai, Hao (H);Liu, Xiaoya (X);Jiang, Yingsong (Y);
 
211.Prognostic nomogram based on coagulation for individualized prediction after radical resection of hepatocellular carcinoma.
  Eur J Med Res.2025 Mar 14;30(1):172.doi:10.1186/s40001-025-02291-2
  Lu, Ming (M);Yuan, Haibo (H);Wu, Mengjie (M);Li, Heng (H);Tu, Congyin (C);Hu, Kongwang (K);
 
212.Construction and validation of a novel liver function-tumor burden-inflammation-nutrition (LTIN) score for HCC patients underwent hepatectomy.
  BMC Cancer.2025 Mar 19;25(1):504.doi:10.1186/s12885-025-13867-w
  Su, Yuhao (Y);Liang, Yuxin (Y);Zhong, Deyuan (D);Yan, Hongtao (H);Yang, Qinyan (Q);Shang, Jin (J);Chen, Yahui (Y);Huang, Xiaolun (X);
 
213.Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer.
  Cell Commun Signal.2025 Mar 19;23(1):145.doi:10.1186/s12964-025-02139-6
  Naik, Adviti (A);Thomas, Remy (R);Al-Khalifa, Aljazi (A);Qasem, Hanan (H);Decock, Julie (J);
 
214.Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma.
  JHEP Rep.2025 Feb 14;7(5):101354.doi:10.1016/j.jhepr.2025.101354
  Tsakiridis, Evangelia E (EE);Ahmadi, Elham (E);Gautam, Jaya (J);Hannah She, Yi Ran (YR);Fayyazi, Russta (R);Lally, James S V (JSV);Wang, Simon (S);Di Pastena, Fiorella (F);Valvano, Celina M (CM);Del Rosso, Daniel (D);Biziotis, Olga-Demetra (OD);Meyers, Brandon (B);Muti, Paola (P);Tsakiridis, Theodoros (T);Steinberg, Gregory R (GR);
 
215.Mechanistic insights into Uc001kfo-induced hepatocellular carcinoma metastasis.
  Discov Oncol.2025 Mar 01;16(1):260.doi:10.1007/s12672-025-02000-9
  Pan, Yanfeng (Y);Liu, Qin (Q);Li, Qingqing (Q);Ren, Zhenjun (Z);
 
216.Y-Transarterial Radioembolization Combined with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Systematic Review.
  J Gastrointest Cancer.2025 Mar 02;56(1):73.doi:10.1007/s12029-025-01189-w
  Hosseini Shabanan, Sedighe (S);Shobeiri, Parnian (P);Behnoush, Amir Hossein (AH);Haghshomar, Maryam (M);Fowler, Kathryn J (KJ);Lewandowski, Robert J (RJ);
 
217.Potential mechanism of circKIAA1429 accelerating the progression of hepatocellular carcinoma.
  Infect Agent Cancer.2025 Mar 01;20(1):12.doi:10.1186/s13027-025-00645-3
  Yuan, Yiting (Y);Huang, Junwei (J);Wei, Guifen (G);Hu, Guang (G);Yu, Hongmei (H);Tao, Yiming (Y);
 
218.A novel telomere-associated genes signature for the prediction of prognosis and treatment responsiveness of hepatocellular carcinoma.
  Biol Proced Online.2025 Feb 27;27(1):8.doi:10.1186/s12575-025-00271-8
  Kang, Kuo (K);Nie, Hui (H);Kuang, Weilu (W);Li, Xuanxuan (X);Zhou, Yangying (Y);
 
219.Hypothermic Oxygenated Machine Perfusion and Static Cold Storage Drive Distinct Immunomodulation During Liver Transplantation: A Pilot Study.
  Transplantation.2024 Dec 11;109(4):658-670.doi:10.1097/TP.0000000000005274
  Aspord, Caroline (C);Macek Jílková, Zuzana (Z);Bonadona, Agnes (A);Gerster, Theophile (T);Lesurtel, Mickael (M);Girard, Edouard (E);Saas, Philippe (P);Decaens, Thomas (T);
 
220.Multicenter evaluation of abbreviated MRI and ultrasound for detecting early-stage hepatocellular carcinoma.
  JHEP Rep.2025 Feb 12;7(5):101357.doi:10.1016/j.jhepr.2025.101357
  Seif El Dahan, Karim (K);Yokoo, Takeshi (T);Daher, Darine (D);Davenport, Matthew S (MS);Fetzer, David T (DT);Mendiratta-Lala, Mishal (M);Rich, Nicole E (NE);Yang, Edward (E);Parikh, Neehar D (ND);Singal, Amit G (AG);
 
221.Comparison of selective intra-arterial to standard intravenous administration in percutaneous electrochemotherapy (pECT) for liver tumors.
  Radiol Oncol.2025 Feb 27;59(1):100-109.doi:10.2478/raon-2025-0017
  Wilke, Tim (T);Hussain, Erschad (E);Spallek, Hannah (H);Terlizzi, Francesca de (F);Mir, Lluis M (LM);Bischoff, Peter (P);Schäfer, Andreas (A);Bartmuß, Elke (E);Cadossi, Matteo (M);Zanasi, Alessandro (A);Pinkawa, Michael (M);Kovács, Attila (A);
 
222.Citronellol Attenuates High Glucose-Induced Oxidative Stress and Inflammatory Responses in HepG2 Cells.
  Cell J.2025 Feb 23;26(10):602-610.doi:10.22074/cellj.2025.2026976.1554
  Choghakhori, Razieh (R);Azadpour, Mojgan (M);Abbasnezhad, Amir (A);Ebrahimzadeh, Farzad (F);Ahmadvand, Hassan (H);
 
223.The value of contrast-enhanced ultrasound fusion imaging in percutaneous liver biopsy for liver lesions invisible on conventional B-mode ultrasound.
  Quant Imaging Med Surg.2025 Jan 22;15(2):1528-1542.doi:10.21037/qims-24-1104
  He, Yuhong (Y);Gong, Li (L);Wu, Jie (J);Wen, Baojie (B);Kong, Wentao (W);
 
224.Predictors of Non-response to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre Real World Study (HCC-AB Study).
  J Clin Exp Hepatol.2025 Feb 08;15(4):102513.doi:10.1016/j.jceh.2025.102513
  Singh, Satender P (SP);Kumar, Karan (K);Kulkarni, Anand (A);Arora, Vinod (V);Choudhury, Ashok (A);Chaubal, Alisha (A);Rathi, Sahaj (S);Shah, Samir (S);Taneja, Sunil (S);Kumar, Ashish (A);Duseja, Ajay (A);Kumar, Guresh (G);Nagaraja Rao, P (P);Saraswat, Vivek (V);Sarin, Shiv K (SK);
 
225.Conventional transarterial chemoembolization followed by irreversible electroporation for hepatocellular carcinoma.
  BMC Cancer.2025 Feb 21;25(1):313.doi:10.1186/s12885-025-13570-w
  Zhao, Meng (M);Li, Fubao (F);Tian, Chuan (C);Cai, Duo (D);Wang, Congxiao (C);
 
226.KAT7-acetylated YBX1 promotes hepatocellular carcinoma proliferation by reprogramming nucleotide metabolism.
  BMC Cancer.2025 Feb 21;25(1):311.doi:10.1186/s12885-025-13708-w
  Huang, He (H);Ren, Longfei (L);Zhou, Yongqiang (Y);Chen, Pengyu (P);Zhao, Haixia (H);Li, Shang (S);Wang, Haiping (H);Li, Xun (X);
 
227.The microRNA landscape and regulatory network in Clonorchis sinensis-infected hepatocellular carcinoma: implications for tumor progression.
  Parasit Vectors.2025 Feb 21;18(1):68.doi:10.1186/s13071-025-06689-z
  Wei, Caibiao (C);Chen, Junxian (J);Huang, Taijun (T);Zhou, Lingling (L);Xu, Yulong (Y);Lin, Qiumei (Q);Qin, Yuling (Y);Tang, Zeli (Z);Yang, Weilong (W);Fang, Min (M);
 
228.Radiofrequency ablation for peribiliary hepatocellular carcinoma: propensity score matching analysis.
  Insights Imaging.2025 Feb 19;16(1):45.doi:10.1186/s13244-025-01919-5
  Cui, Jin (J);Sui, Xinzi (X);Liu, Kaiwen (K);Huang, Min (M);Zheng, Yuanwen (Y);Zhao, Xinya (X);Wang, Gongzheng (G);Wang, Ximing (X);
 
229.Huqi formula suppresses hepatocellular carcinoma growth by modulating the PI3K/AKT/mTOR pathway and promoting T cell infiltration.
  Chin Med.2025 Feb 19;20(1):25.doi:10.1186/s13020-025-01061-w
  Yin, Donghao (D);Li, Xiang (X);Yang, Xuemeng (X);Shang, Xiaofei (X);Li, Zhen (Z);Geng, Jiahao (J);Xu, Yanyu (Y);Xu, Zijing (Z);Wang, Zixuan (Z);Shang, Zimeng (Z);Yang, Zhiyun (Z);Hu, Linlan (L);Li, Quanwei (Q);Wang, Jiabo (J);Song, Xinhua (X);Li, Xiuhui (X);Wang, Xiaojun (X);
 
230.G2M-checkpoint related immune barrier structure and signature for prognosis and immunotherapy response in hepatocellular carcinoma: insights from spatial transcriptome and machine learning.
  J Transl Med.2025 Feb 18;23(1):202.doi:10.1186/s12967-024-06051-4
  Chen, Xingte (X);Wu, Shiji (S);He, Hongxin (H);Tang, Jingjing (J);Zhong, Yaqi (Y);Fang, Huipeng (H);Huang, Qizhen (Q);Hong, Liang (L);Shao, Lingdong (L);Wu, Junxin (J);
 
231.Integration of single-cell and spatial transcriptomics reveals fibroblast subtypes in hepatocellular carcinoma: spatial distribution, differentiation trajectories, and therapeutic potential.
  J Transl Med.2025 Feb 18;23(1):198.doi:10.1186/s12967-025-06192-0
  Liu, Yue (Y);Dong, Guoping (G);Yu, Jie (J);Liang, Ping (P);
 
232.Efficacy and safety of postoperative adjuvant HAIC with FOLFOX combining PD-1 inhibitors in HCC patients with microvascular invasion: a propensity score matching analysis.
  BMC Cancer.2025 Mar 07;25(1):418.doi:10.1186/s12885-025-13793-x
  Liang, Yuxin (Y);Zhong, Deyuan (D);Shang, Jin (J);Yan, Hongtao (H);Su, Yuhao (Y);Chen, Yahui (Y);Yang, Qinyan (Q);Huang, Xiaolun (X);
 
233.Evaluation of the efficacy and safety of combined surgery with intraoperative radiotherapy and postoperative PVC for hepatocellular carcinoma with mPVTT.
  Eur J Surg Oncol.2025 Mar 05;51(7):109727.doi:10.1016/j.ejso.2025.109727
  Song, Zebing (Z);Li, Hang (H);Chen, Hailong (H);Du, Bingqing (B);Cheng, Zongbing (Z);Mo, Zengyi (Z);Huang, Zejun (Z);Hu, Sihan (S);Feng, Yujian (Y);Deng, Wujian (W);Liang, Huihong (H);Yang, Xuewei (X);Song, Xiaodong (X);Shao, Zili (Z);
 
234.The collagen-modifying enzyme GLT25D1 is a prognostic indicator related to immunosuppression and malignant phenotypes in hepatocellular carcinoma.
  Cancer Cell Int.2025 Mar 08;25(1):84.doi:10.1186/s12935-025-03715-z
  Qiu, Sheng (S);Han, Hongdong (H);Zhang, Hongmin (H);Yang, Mengliu (M);Wang, Hao (H);Li, Ke (K);Li, Ling (L);Yang, Gangyi (G);
 
235.Transforming liver transplant allocation with artificial intelligence and machine learning: a systematic review.
  BMC Med Inform Decis Mak.2025 Feb 24;25(1):98.doi:10.1186/s12911-025-02890-3
  Pruinelli, Lisiane (L);Balakrishnan, Kiruthika (K);Ma, Sisi (S);Li, Zhigang (Z);Wall, Anji (A);Lai, Jennifer C (JC);Schold, Jesse D (JD);Pruett, Timothy (T);Simon, Gyorgy (G);
 
236.Analysis of risk factors and construction of prediction model for lower extremity deep vein thrombosis after liver transplantation.
  Eur J Med Res.2025 Feb 24;30(1):127.doi:10.1186/s40001-025-02367-z
  Xiao, Yang (Y);Guo, Ran (R);Yang, Haitao (H);Geng, Xiaoyong (X);
 
237.Outcomes and risk factors for liver transplantation using steatotic grafts for hepatocellular carcinoma: a multicenter study.
  Eur J Surg Oncol.2025 Apr 16;51(8):110061.doi:10.1016/j.ejso.2025.110061
  Wang, Kai (K);Dong, Libin (L);Wang, Xiaobo (X);Wang, Zhoucheng (Z);Qiu, Xun (X);Xu, Hanzhi (H);Xu, Xiao (X);
 
238.Is ambulance conveyance associated with distance to hospital and patient outcomes? A register-based cohort study in Region Zealand, Denmark, 2017-2022.
  BMJ Open.2025 Apr 27;15(4):e097283.doi:10.1136/bmjopen-2024-097283
  Jensen, Josefine Tangen (JT);Møller, Thea Palsgaard (TP);Wolthers, Signe Amalie (SA);Blomberg, Stig Nikolaj Fasmer (SNF);Ersbøll, Annette (A);Christensen, Helle Collatz (HC);
 
239.Evolving epidemiology of HCC in Spain.
  JHEP Rep.2025 Jan 30;7(5):101336.doi:10.1016/j.jhepr.2025.101336
  Sala, Margarita (M);Pascual, Sonia (S);Rota Roca, Maria Rosa (MR);Matilla, Ana María (AM);Campos, Marta (M);Delgado, Manuel (M);Ferrer, María Teresa (MT);Montero, José Luís (JL);González-Santiago, Jesús Manuel (JM);Guerrero, Antonio (A);Aracil, Carles (C);Rodríguez-Lope, Carlos (C);Romero-Gutiérrez, Marta (M);Sogbe, Miguel (M);Vázquez-Rodríguez, Sergio (S);Olmo, Javier Fuentes (JF);Mínguez, Beatriz (B);Cortés-García, Luís (L);Vallejo-Senra, Nicolau (N);Unceta, Paloma Rendón (PR);Clos, Ariadna (A);Díaz-Bethencourt, Dácil (D);Sánchez, Araceli García (AG);Castro, Raisa Quiñones (RQ);Bustamante, Javier (J);Perelló, Christie (C);Urquijo Ponce, Juan José (JJ);Serra, Hernán Andreu (HA);Llamoza-Torres, Camilo Julio (CJ);Montoliu, Silvia (S);Fernández-Marcos, Cristina (C);Guiberteau, Ana (A);Hernández-Guerra, Manuel (M);Vergara, Mercedes (M);Fernández-López, Alexia María (AM);Valer López-Fando, María Paz (MP);Gutiérrez-García, María Luisa (ML);Hernáez-Alsina, Tánia (T);Coll, Susana (S);Cuyás, Berta (B);Morillas, María Julia (MJ);Olmedo, Susana Rebolledo (SR);Fernández-Bermejo, Miguel (M);Roget, Mercè (M);Ramos, Irina Calvo (IC);Pacheco Del Río, Gemma (G);Rifà, Raimon (R);Gacho, Pilar Conde (PC);Barrio, Mónica Llorente (ML);Gómez-Rubio, Mariano (M);Peñas, Irene (I);Serra, Isabel (I);Cachero, Alba (A);Reig, María (M);Giraldez, Álvaro (Á);Guerrero, Marta (M);Segarra, José Xavier (JX);Lledó, José Luis (JL);Díaz-González, Álvaro (Á);Delgado, Carolina (C);Iñarrairaegui, Mercedes (M);Rodríguez-González, María Milagros (MM);Lázaro, María (M);Bermúdez-Ramos, María (M);Lué, Alberto (A);Molina, Esther (E);Macías-Rodríguez, Manuel Alberto (MA);Rodríguez, Manuel (M);Chiminazzo, Valentina (V);Varela, María (M);
 
240.Outcomes of Living Donor Liver Transplantation in Recipients Colonized With Carbapenem-Resistant Enterobacterales.
  J Clin Exp Hepatol.2025 Jan 25;15(4):102508.doi:10.1016/j.jceh.2025.102508
  Rajakumar, Akila (A);Ramanan, Prijith (P);Sam, Amal F (AF);Devarajan, Vidya (V);Sundaramoorthy, Subha (S);Jothimani, Dinesh (D);Rammohan, Ashwin (A);Rela, Mohamed (M);
 
241.Angiogenesis Is Associated With Aggressive Biology That Counterbalances With Tumor Immunogenicity in Hepatocellular Carcinoma.
  World J Oncol.2025 Jan 25;16(2):173-181.doi:10.14740/wjon2009
  Vaghjiani, Raj (R);Wu, Rongrong (R);Tung, Kaity H (KH);Ishikawa, Takashi (T);Takabe, Kazuaki (K);
 
242.Assessing the effect of modifiable risk factors on hepatocellular carcinoma: evidence from a bidirectional Mendelian randomization analysis.
  Discov Oncol.2025 Mar 31;16(1):437.doi:10.1007/s12672-025-02177-z
  Wei, Lijuan (L);Ding, Enci (E);Lu, Dongyan (D);Rui, Zhongying (Z);Shen, Jie (J);Fan, Guoju (G);
 
243.Whole-genome bisulfite sequencing of cell-free DNA unveils age-dependent and ALS-associated methylation alterations.
  Cell Biosci.2025 Feb 20;15(1):26.doi:10.1186/s13578-025-01366-1
  Jin, Yulin (Y);Conneely, Karen N (KN);Ma, Wenjing (W);Naviaux, Robert K (RK);Siddique, Teepu (T);Allen, Emily G (EG);Guingrich, Sandra (S);Pascuzzi, Robert M (RM);Jin, Peng (P);
 
244.Rare Encounter: A Case Report of Hepatic Perivascular Epithelioid Cell Tumor - An Uncommon Mesenchymal Tumor in the Liver.
  Case Rep Gastroenterol.2025 Jan 24;19(1):43-51.doi:10.1159/000543018
  Paula, Diogo (D);Amaral, Maria João (MJ);Madeira, Joana (J);Simões, João (J);Lázaro, André (A);Silva, Nuno (N);Tralhão, José Guilherme (JG);
 
245.Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer.
  Gastro Hep Adv.2025 Jan 23;4(5):100621.doi:10.1016/j.gastha.2025.100621
  Antwi, Samuel O (SO);Jnr Siaw, Ampem Darko (AD);Armasu, Sebastian M (SM);Frank, Jacob A (JA);Yan, Irene K (IK);Ahmed, Fowsiyo Y (FY);Izquierdo-Sanchez, Laura (L);Boix, Loreto (L);Rojas, Angela (A);Banales, Jesus M (JM);Reig, Maria (M);Stål, Per (P);Gómez, Manuel Romero (MR);Wangensteen, Kirk J (KJ);Singal, Amit G (AG);Roberts, Lewis R (LR);Patel, Tushar (T);
 
246.A prior information-based multi-population multi-objective optimization for estimating F-FDG PET/CT pharmacokinetics of hepatocellular carcinoma.
  BMC Med Imaging.2025 Feb 24;25(1):59.doi:10.1186/s12880-024-01534-8
  Xiong, Yiwei (Y);Li, Siming (S);He, Jianfeng (J);Wang, Shaobo (S);
 
247.Histone Lactylation-Driven Ubiquitin-Specific Protease 34 Promotes Cisplatin Resistance in Hepatocellular Carcinoma.
  Gastroenterology Res.2025 Jan 17;18(1):23-30.doi:10.14740/gr1796
  Fan, Ming (M);Liu, Jian Shan (JS);Wei, Xi Le (XL);Nie, Ye (Y);Liu, Hai Liang (HL);
 
248.Berberine in combination with anti-PD-L1 suppresses hepatocellular carcinoma progression and metastasis via Erk signaling pathway.
  Ann Med Surg (Lond).2025 Jan 09;87(1):103-112.doi:10.1097/MS9.0000000000002746
  Miao, Ganggang (G);Zhang, Zhiyu (Z);Wang, Meiyan (M);Gu, Xingwei (X);Xiang, Dongxiao (D);Cao, Hongyong (H);
 
249.Liver microsomal protein content and activity in patients with hepatocellular carcinoma and cirrhosis: implications for the prediction of individual hepatic clearance.
  J Gastrointest Oncol.2025 Feb 24;16(1):146-158.doi:10.21037/jgo-2024-963
  Zhou, Jun (J);Gao, Na (N);Tian, Xin (X);Fang, Yan (Y);Gao, Jie (J);Wen, Qiang (Q);Cui, Ming-Zhu (MZ);Zhang, Yun-Fei (YF);Li, Sai-Fei (SF);Jia, Lin-Jing (LJ);Qiao, Hai-Ling (HL);
 
250.Real-world effectiveness and safety of TACE combined with lenvatinib plus immune checkpoint inhibitors in patients with BCLC-B stage hepatocellular carcinoma.
  J Gastrointest Oncol.2025 Feb 26;16(1):176-190.doi:10.21037/jgo-2025-33
  Yao, Yu (Y);Nong, Xiang (X);Liang, Jing-Chang (JC);Zhang, Yu-Mei (YM);Zhang, Zhi-Ming (ZM);
 
251.Systemic treatment for recurrence of hepatocellular carcinoma after liver transplantation: a case report.
  J Gastrointest Oncol.2025 Feb 26;16(1):309-316.doi:10.21037/jgo-24-480
  Deng, Miaotian (M);Chen, Chaobo (C);Wang, Kun (K);Li, Binghua (B);Yu, Decai (D);
 
252.Progress in ubiquitination and hepatocellular carcinoma: a bibliometric analysis.
  Discov Oncol.2025 Mar 21;16(1):371.doi:10.1007/s12672-025-02155-5
  Li, Ming (M);Xu, Zhiliang (Z);Liang, Siqin (S);Lv, Qiaoli (Q);You, Xiaoxiang (X);Yuan, Tinghao (T);He, Jun (J);Tu, Qiang (Q);
 
253.NDRG1 alleviates Erastin-induced ferroptosis of hepatocellular carcinoma.
  BMC Cancer.2025 Mar 21;25(1):522.doi:10.1186/s12885-025-13954-y
  Li, Liuzheng (L);Wu, Tong (T);Gong, Guocha (G);Li, Bo (B);Feng, Jiawei (J);Xu, Leisheng (L);Zhao, Hairong (H);Gao, Xuechang (X);
 
254.Adjuvant PD-1 inhibitors improve recurrence and survival outcomes in high-risk hepatocellular carcinoma patients after curative hepatectomy.
  Eur J Med Res.2025 Mar 22;30(1):196.doi:10.1186/s40001-025-02444-3
  Shen, Xuehan (X);Yan, Wei (W);Zhang, Erlei (E);Zhang, Zhiwei (Z);Zhang, Zunyi (Z);Dong, Hanhua (H);
 
255.Integrating single-cell and bulk RNA sequencing data to characterize the heterogeneity of glycan-lipid metabolism polarization in hepatocellular carcinoma.
  J Transl Med.2025 Mar 22;23(1):358.doi:10.1186/s12967-025-06347-z
  Lin, Peng (P);Qin, Qiong (Q);Gan, Xiang-Yu (XY);Pang, Jin-Shu (JS);Wen, Rong (R);He, Yun (Y);Yang, Hong (H);
 
256.Knockdown of Plexin C1 induces epithelial-to-mesenchymal transition and confers resistance to multikinase inhibitors in hepatocellular carcinoma cells.
  Turk J Biol.2025 Jan 08;49(2):219-232.doi:10.55730/1300-0152.2739
  Topcu, Gamze Güngör (GG);Aysan, Arzu (A);Dik, ?evval (?);?eker, Maide (M);Bahçekapili, Melike Binnur (MB);Topkarao?lu, Sude (S);Yavuzer, Dilek (D);Ya?ci, Tamer (T);
 
257.Comparing mortality rates, risk, and trends of hip fracture and common cancers in Hong Kong, 2010-2020: A population-based study.
  Osteoporos Sarcopenia.2025 Jan 07;11(1):15-21.doi:10.1016/j.afos.2024.12.001
  Zhang, Xiaowen (X);Sing, Chor-Wing (CW);Au, Philip Cm (PC);Tan, Kathryn Choon-Beng (KC);Wong, Ian Chi-Kei (IC);Cheung, Ching-Lung (CL);
 
258.Surgery and neoadjuvant therapy in locally advanced pancreatic cancer: an umbrella review of survival, resection outcomes, and cost-effectiveness.
  Gland Surg.2025 Mar 26;14(3):529-542.doi:10.21037/gs-24-421
  Zhao, Yun (Y);Tan, Hwee Leong (HL);Chua, Darren Weiquan (DW);Goh, Brian Kim Poh (BKP);Koh, Ye Xin (YX);
 
259.Blocking the SIRP?-CD47 axis promotes macrophage phagocytosis of exosomes derived from visceral adipose tissue and improves inflammation and metabolism in mice.
  J Biomed Sci.2025 Feb 28;32(1):31.doi:10.1186/s12929-025-01124-y
  Lin, Yun-Kai (YK);Pan, Yu-Fei (YF);Jiang, Tian-Yi (TY);Chen, Yi-Bin (YB);Shang, Tai-Yu (TY);Xu, Meng-You (MY);Feng, Hui-Bo (HB);Ma, Yun-Han (YH);Tan, Ye-Xiong (YX);Wang, Hong-Yang (HY);Dong, Li-Wei (LW);
 
260.Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study.
  Eur J Surg Oncol.2025 Feb 15;51(6):109706.doi:10.1016/j.ejso.2025.109706
  Montalti, Roberto (R);Pepe, Francesco (F);Cassese, Gianluca (G);Russo, Gianluca (G);Malapelle, Umberto (U);Carlomagno, Chiara (C);Giglio, Mariano Cesare (MC);Falco, Giacinto (G);Alagia, Mariantonietta (M);De Simone, Giuseppe (G);Geboes, Karen (K);Troncone, Giancarlo (G);Troisi, Roberto Ivan (RI);Rompianesi, Gianluca (G);
 
261.Extreme surgery using the hypothermic perfusion technique for conventionally unresectable abdominal malignant tumours: A systematic review and meta-analysis.
  Eur J Surg Oncol.2025 Feb 11;51(5):109692.doi:10.1016/j.ejso.2025.109692
  Li, Lianbo (L);Hirukawa, Kazuya (K);Morinaga, Jun (J);Goto, Toru (T);Isono, Kaori (K);Honda, Masaki (M);Sugawara, Yasuhiko (Y);Hibi, Taizo (T);
 
262.Aphthous-Like Stomatitis in a Patient Receiving Panitumumab.
  J Oral Maxillofac Res.2024 Dec 31;15(4):e5.doi:10.5037/jomr.2024.15405
  Kouri, Maria (M);Papadopoulou, Erofili (E);Tziveleka, Styliani (S);Velonis, Dimitrios (D);Georgaki, Maria (M);Piperi, Evangelia (E);Vardas, Emmanouil (E);Nikitakis, Nikolaos G (NG);
 
263.Serum bile acids early after portoenterostomy are predictive for native liver survival and portal hypertension in biliary atresia.
  J Pediatr Gastroenterol Nutr.2024 Dec 29;80(3):462-470.doi:10.1002/jpn3.12451
  Anderson, Linda (L);Hukkinen, Maria (M);Nyholm, Iiris (I);Niemi, Mikko (M);Pakarinen, Mikko P (MP);
 
264.Tumor-immune partitioning and clustering algorithm for identifying tumor-immune cell spatial interaction signatures within the tumor microenvironment.
  PLoS Comput Biol.2025 Feb 18;21(2):e1012707.doi:10.1371/journal.pcbi.1012707
  Lau, Mai Chan (MC);Borowsky, Jennifer (J);Väyrynen, Juha P (JP);Haruki, Koichiro (K);Zhao, Melissa (M);Dias Costa, Andressa (A);Gu, Simeng (S);da Silva, Annacarolina (A);Ugai, Tomotaka (T);Arima, Kota (K);Nguyen, Minh N (MN);Takashima, Yasutoshi (Y);Yeong, Joe (J);Tai, David (D);Hamada, Tsuyoshi (T);Lennerz, Jochen K (JK);Fuchs, Charles S (CS);Wu, Catherine J (CJ);Meyerhardt, Jeffrey A (JA);Ogino, Shuji (S);Nowak, Jonathan A (JA);
 
265.Glutathiones' life in multi-cancers: especially their potential micropetides in liver hepatocellular carcinoma.
  Discov Oncol.2025 Feb 18;16(1):201.doi:10.1007/s12672-025-01945-1
  Ma, Didi (D);Wu, Zhenguo (Z);Zhang, Mengying (M);Mao, Jian (J);Xu, Wenqin (W);Jiang, Lan (L);Wang, Zuzhen (Z);
 
266.Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer.
  Radiat Oncol.2025 Feb 18;20(1):23.doi:10.1186/s13014-025-02594-y
  Hoffmeister-Wittmann, Paula (P);Hoegen-Saßmannshausen, Philipp (P);Wicklein, Livia (L);Weykamp, Fabian (F);Seidensaal, Katharina (K);Springfeld, Christoph (C);Dill, Michael T (MT);Longerich, Thomas (T);Schirmacher, Peter (P);Mehrabi, Arianeb (A);Mathy, René Michael (RM);Köhler, Bruno C (BC);Debus, Jürgen (J);Herfarth, Klaus (K);Liermann, Jakob (J);
 
267.Early Allograft Dysfunction after liver transplantation- definition, incidence and relevance in a single-centre analysis.
  Langenbecks Arch Surg.2025 Feb 19;410(1):76.doi:10.1007/s00423-025-03633-8
  Wiemann, Bengt A (BA);Beetz, Oliver (O);Weigle, Clara A (CA);Tessmer, Philipp (P);Störzer, Simon (S);Kleine-Döpke, Dennis (D);Vondran, Florian W R (FWR);Richter, Nicolas (N);Schmelzle, Moritz (M);Oldhafer, Felix (F);
 
268.Application and assessment of NNN linkages in liver transplant postoperative care: a prospective study.
  BMC Nurs.2025 Feb 19;24(1):195.doi:10.1186/s12912-025-02816-4
  Shen, MingYan (M);Han, LinQiu (L);Shi, ZuXin (Z);Feng, ZhiXian (Z);
 
269.Statin use and liver-related prognosis among patients with MASLD.
  JHEP Rep.2024 Dec 24;7(4):101313.doi:10.1016/j.jhepr.2024.101313
  Yun, Byungyoon (B);Park, Heejoo (H);Lee, Jian (J);Kim, Beom Kyung (BK);Yoon, Jin-Ha (JH);
 
270.Endovascular Management of a Portal Vein Pseudoaneurysm following Pancreatoduodenectomy: A Case Report and Review of Literature.
  Case Rep Gastroenterol.2024 Dec 23;19(1):7-13.doi:10.1159/000542585
  Oor, Jelmer E (JE);Groeneweg, Eline (E);Bloemsma, Gijs C (GC);Bokkers, Reinoud P H (RPH);Klaase, Joost M (JM);
 
271.Treatment outcomes of hepatectomy and systemic chemotherapy based on oncological resectability criteria for hepatocellular carcinoma.
  Ann Gastroenterol Surg.2024 Dec 20;9(2):235-243.doi:10.1002/ags3.12893
  Komatsu, Shohei (S);Yano, Yoshihiko (Y);Ishihara, Nobuaki (N);Kido, Masahiro (M);Gon, Hidetoshi (H);Fukushima, Kenji (K);Urade, Takeshi (T);Yanagimoto, Hiroaki (H);Toyama, Hirochika (H);Fukumoto, Takumi (T);
 
272.LAPTM4B enhances the stemness of CD133 liver cancer stem-like cells via WNT/?-catenin signaling.
  JHEP Rep.2024 Dec 20;7(4):101306.doi:10.1016/j.jhepr.2024.101306
  Wang, Jiahong (J);Liao, Jianping (J);Cheng, Ye (Y);Chen, Meirong (M);Huang, Aimin (A);
 
273.Novel ABCB4 mutation in a female patient with progressive familial intrahepatic cholestasis type 3: a case report and literature review.
  Ann Med Surg (Lond).2024 Dec 19;87(2):953-963.doi:10.1097/MS9.0000000000002813
  Sharabati, Israa (I);Qafesha, Ruaa Mustafa (RM);Mustafa, Mohamed M M (MMM);Hindawi, Mahmoud Diaa (MD);Rasras, Heba (H);Bannoura, Sami (S);Abdulrazzak, Mohammed (M);Shamasneh, Ibrahim (I);
 
274.Sintilimab plus bevacizumab followed by resection in intermediate-stage hepatocellular carcinoma: a phase Ib clinical trial with biomarker analysis.
  BMJ Oncol.2024 Dec 16;3(1):e000578.doi:10.1136/bmjonc-2024-000578
  Sun, Hui-Chuan (HC);Zhu, Xiao-Dong (XD);Wang, Zi-Yi (ZY);Gao, Qiang (Q);Ji, Yuan (Y);Shi, Ying-Hong (YH);Wang, Xiao-Ying (XY);Qiu, Shuang-Jian (SJ);Huang, Cheng (C);Shen, Ying-Hao (YH);Zhou, Jian (J);Fan, Jia (J);
 
275.Unraveling the immune-activated tumor microenvironment correlated with clinical response to atezolizumab plus bevacizumab in advanced HCC.
  JHEP Rep.2024 Dec 15;7(4):101304.doi:10.1016/j.jhepr.2024.101304
  Lim, Jinyeong (J);Goh, Myung Ji (MJ);Song, Byeong Geun (BG);Sinn, Dong Hyun (DH);Kang, Wonseok (W);Gwak, Geum-Youn (GY);Choi, Moon Seok (MS);Lee, Joon Hyeok (JH);Cha, Dong Ik (DI);Gu, Kyowon (K);Ha, Sang Yun (SY);Hwang, Inwoo (I);Park, Woong-Yang (WY);Paik, Yong-Han (YH);
 
276.Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations.
  Gastro Hep Adv.2024 Dec 12;4(4):100599.doi:10.1016/j.gastha.2024.100599
  Hadefi, Alia (A);Leprovots, Morgane (M);Dinsart, Gilles (G);Marefati, Maryam (M);Vermeersch, Marjorie (M);Monteyne, Daniel (D);Pérez-Morga, David (D);Lefort, Anne (A);Libert, Frédérick (F);Verset, Laurine (L);Liefferinckx, Claire (C);Moreno, Christophe (C);Devière, Jacques (J);Trépo, Eric (E);Garcia, Marie-Isabelle (MI);
 
277.Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome.
  JHEP Rep.2024 Dec 10;7(3):101297.doi:10.1016/j.jhepr.2024.101297
  Robert, Fabien (F);Benchenouf, Feriel (F);Ha, My Ngoc (MN);Cuomo, Alessandra (A);Ottaviani, Mina (M);Surbier, Maxime (M);Thuillet, Raphaël (R);Normand, Corinne (C);Dumont, Florent (F);Verstuyft, Céline (C);Fiore, Frederic (F);Guinut, Frederic (F);Humbert, Marc (M);Coilly, Audrey (A);Gonzales, Emmanuel (E);Sitbon, Olivier (O);Tu, Ly (L);Guignabert, Christophe (C);Savale, Laurent (L);
 
278.Pan?cancer analysis of the oncogenic role of telomeric repeat binding factor 2 (TERF2) in human tumors and in vitro validation in gastric cancer by TERF2 knockdown.
  Discov Oncol.2025 Feb 24;16(1):234.doi:10.1007/s12672-025-01954-0
  Ma, Qiang (Q);Xu, Wen (W);Guo, Xiaolan (X);
 
279.Molecular MRI of T-cell immune response to cryoablation in immunologically hot . cold hepatocellular carcinoma.
  JHEP Rep.2024 Dec 04;7(3):101294.doi:10.1016/j.jhepr.2024.101294
  Santana, Jessica Gois (JG);Shewarega, Annabella (A);Nam, David (D);Duncan, James (J);Madoff, David Craig (DC);Hyder, Fahmeed (F);Coman, Daniel (D);Chapiro, Julius (J);
 
280.Exploring the association between chemotherapy and prognosis among patients less than 50 years old with hepatocellular carcinoma: a retrospective cohort study based on the SEER database.
  Discov Oncol.2025 May 07;16(1):682.doi:10.1007/s12672-025-02490-7
  Zhang, Qiyu (Q);Liang, Qiongyu (Q);Xu, Chi (C);
 
281.An elevated percentage of CD4?CD25?CD127 regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy.
  BMC Gastroenterol.2025 May 07;25(1):340.doi:10.1186/s12876-025-03940-w
  Sun, Haoran (H);Cao, Zepeng (Z);Zhao, Baochen (B);Zhou, Dachen (D);Chen, Zhongbiao (Z);Zhang, Bin (B);
 
282.Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
  J Exp Clin Cancer Res.2025 May 07;44(1):139.doi:10.1186/s13046-025-03386-8
  Zhao, Bixing (B);Zhou, Yang (Y);Cheng, Niangmei (N);Zheng, Xiaoyuan (X);Chen, Geng (G);Qi, Xin (X);Zhang, Xiangzhi (X);Wang, Fei (F);Zhuang, Qiuyu (Q);Assaraf, Yehuda G (YG);Liu, Xiaolong (X);Wang, Yingchao (Y);Zeng, Yongyi (Y);
 
283.PAQR5 drives the malignant progression and shapes the immunosuppressive microenvironment of hepatocellular carcinoma by activating the NF-?B signaling.
  Biomark Res.2025 May 07;13(1):70.doi:10.1186/s40364-025-00785-z
  Yang, Ruida (R);Wang, Huanhuan (H);Wu, Cong (C);Shi, Yu (Y);Li, Hanqi (H);Bao, Xinyue (X);Yang, Yuqian (Y);Han, Shaoshan (S);Yang, Xue (X);Tao, Jie (J);Sun, Hao (H);Wu, Shaobo (S);Sun, Liankang (L);
 
284.Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinoma.
  J Natl Cancer Cent.2024 Nov 28;5(1):38-49.doi:10.1016/j.jncc.2024.06.007
  Zhao, Cai-Ning (CN);Chiang, Chi-Leung (CL);Chiu, Wan-Hang Keith (WK);Chan, Sik-Kwan Kenneth (SK);Li, Chun-Bong James (CJ);Chen, Wei-Wei (WW);Zheng, Dan-Yang (DY);Chen, Wen-Qi (WQ);Ji, Ren (R);Lo, Chung-Mau (CM);Jabbour, Salma K (SK);Chan, Chi-Yan Albert (CA);Kong, Feng-Ming Spring (FS);
 
285.Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis.
  JHEP Rep.2024 Nov 28;7(3):101287.doi:10.1016/j.jhepr.2024.101287
  Zhai, Yirui (Y);Wang, Liming (L);Zhao, Hong (H);Wu, Fan (F);Xin, Lingxia (L);Ye, Feng (F);Sun, Wei (W);Song, Yan (Y);Niu, Lijuan (L);Zeng, Huiying (H);Wang, Jingbo (J);Tang, Yuan (Y);Song, Yongwen (Y);Liu, Yueping (Y);Fang, Hui (H);Lu, Ningning (N);Jing, Hao (H);Qi, Shunan (S);Zhang, Wenwen (W);Wang, Shulian (S);Li, Ye-Xiong (YX);Wu, Jianxiong (J);Chen, Bo (B);
 
286.Causality of blood metabolites on hepatocellular carcinoma and cholangiocarcinoma: a metabolome-wide mendelian randomization study.
  BMC Cancer.2025 Mar 04;25(1):389.doi:10.1186/s12885-025-13690-3
  Ning, Lin (L);Gao, Zhanhua (Z);Chen, Di (D);Han, Jie (J);Xie, Guanyue (G);Sun, Jianguang (J);
 
287.Histidine metabolism drives liver cancer progression via immune microenvironment modulation through metabolic reprogramming.
  J Transl Med.2025 Mar 04;23(1):262.doi:10.1186/s12967-025-06267-y
  Liu, Pengcheng (P);Huang, Fuxin (F);Lin, Peixu (P);Liu, Jiayao (J);Zhou, Pincheng (P);Wang, Jie (J);Sun, Huanhuan (H);Xing, Fan (F);Ma, Haiqing (H);
 
288.MAZ-mediated N6-methyladenosine modification of ZEB1 promotes hepatocellular carcinoma progression by regulating METTL3.
  J Transl Med.2025 Mar 04;23(1):265.doi:10.1186/s12967-025-06314-8
  Li, Di (D);Xu, Li (L);Liu, Ruyuan (R);Yao, Zhaonv (Z);Zheng, Chuanjun (C);Jin, Song (S);Guo, Xuefeng (X);Zhang, Zhengbao (Z);Tan, Shengkui (S);Zhu, Xiaonian (X);
 
289.Current approaches for management of gastric varices in the United States: a survey of providers' attitudes and practices.
  Proc (Bayl Univ Med Cent).2024 Nov 22;38(2):127-134.doi:10.1080/08998280.2024.2430153
  Hashim, Mahmoud A (MA);Elfert, Khaled (K);Afifi, Ahmed M (AM);Hassan, Manal (M);Elkheshen, Ahmed (A);Gagneja, Harish (H);Patel, Kalpesh (K);Satapathy, Sanjaya (S);Kowdley, Kris (K);Jalal, Prasun K (PK);
 
 
 

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

MASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2025 GI Fellow Board of Advisors

Other Resources

Journal Abstracts

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2025 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.